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ABBREVIATIONS 
ACR =   algal crop rotation 
ALA =   α-linolenic acid, C18:3(n-3) 
ARA =   arachidonic acid (also AA) C20:4(n-6) 
BRIC =   Brazil, Russia, India and China 
CAGR =  Compound Annual Growth Rate 
CIP =   cleaning in place, a procedure for cleaning process equipment such as vessels or pipes 
without disassembling them 
DHA =   docosahexaenoic acid, C22:6(n-3) 
DM =   dry matter 
DPA =   docosahexaenoic acid, C22:5 (n-3) 
DSP =   downstream processing 
EFSA =  European Food Safety Authority  
EPA =   eicosapentaenoic acid, C20:5(n-3) 
FA =   fatty acids 
FAME =  fatty acid methyl esters 
FAO =   Food and Agriculture Organization of the United Nations 
FM =   fish meal 
FO =   fish oil  
FPA =   flat panel airlift 
FPB =   flat panel bioreactor 
GMO =  genetically modified organism 
IFFO =  International Fishmeal and Fish Oil Organisation 
MCSGP =  multicolumn counter current solvent gradient purification  
PBR =   photobioreactor 
PE =   photosynthetic efficiency 
PUFA =  polyunsaturated fatty acids 
sCO2 =  supercritical CO2 
SCP =   single cell protein 
SDA =   stearidonic acid 
TAG =   triacylglycerides  
UHT-PBR =  unilayer (single layer) horizontal tubular photobioreactor  
USP =   upstream processing 
WHO =  World Health Organisation 
 
Algae strains used: 
Thalassiosira weissflogii   CCAP 1085/18 
Prorocentrum cassubicum   SAG 40.80 
Chloridella simplex    SAG 51.91 
Raphidonema nivale Lagerheim  CCCryo 381-11 
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Summary 
In Task 9.4 a socio-economic assessment of the systems defined in Task 9.1 was performed for the 
PUFAChain process by Wageningen Research (former DLO). The result is an international working paper 
that documents the approach, method and results of this socio-economic assessment. This includes a 
macro-economic assessment, a LCC (Life Cycle Costing, micro-economic) analysis, followed by an overall 
SWOT analysis taking into account the different parts with emphasis on the socio-economic aspects.   
The macro-economic assessment focuses on market analysis and competiveness and provides 
information about market and price developments. Both peer-reviewed and generic data sources were 
used. The LCC (micro-economic) analysis uses both existing information and tools in development from 
the Interreg project EnAlgae, combined with data from Task 9.1 and the project partners. UNEP/SETAC 
guidelines for LCC were taken into account. The macro- and micro-economic analyses both identify 
profitability and market competiveness of the systems. The SWOT analysis has been updated during the 
project and takes into account the results of the other three analyses. When useful, reference 
systems/products were assessed as well. The integrated socio-economic analysis, presented in a data 
table, includes all major social and micro-economic aspects, such as impacts on employment and public 
acceptance of new technologies. Institutional, legislative and political aspects are included if applicable. 
UNEP/SETAC guidelines for sLCA (social life cycle assessment) and recent methodological literature are 
taken into account. The results will be used as input for Task 9.5. 
 
Macro-economic assessment 
The PUFAChain process will produce algae in industrial-scale photo bioreactors (PBRs). After oil and PUFA 
extraction from the algae the extraction cake from these phototrophic algae can be sold on various markets. 
The main focus of the PUFAChain is on purified EPA or DHA or EPA/DHA mixtures containing high 
EPA/DHA levels.  
 
EPA/DHA consumer market - The global EPA/DHA consumer market has been growing fast and is 
expected to keep on growing in the future. Driving factors are positive clinical research outcomes, regulatory 
recognition, increasing consumer health awareness and improved living standards on several continents. 
The largest EPA/DHA market segments by application are respectively dietary supplements, 
pharmaceuticals, infant formulas and functional foods. In terms of market value, the largest market segment 
is concentrates because of their higher prices, particularly for pharmaceuticals. Key suppliers have 
developed ultra-high concentrates, which have EPA and DHA concentrations of up to 90 % for both the 
pharmaceutical and the nutraceutical market. At the moment the largest share of the EPA/DHA oil market 
volume and value originates from wild fish and only a minority share from algae, but algae oils have a larger 
share in market value than in volume. The EPA/DHA consumer market leader sells algae based DHA 
(mainly for infant formulas) and EPA/DHA products. They are produced by protists (also called unicellular 
marine heterotrophic organisms) that are grown on sugar in closed fermentation vessels (without light 
contrary to phototrophic algae). The need to find new sources of EPA and DHA because of depleting wild 
fish stocks and concerns about contaminations is an opportunity for algae based PUFAs. The absence of 
fishy taste/smell and appealing labels like “vegetarian/vegan”, “kosher” or “organic” distinguish algal oil from 
fish oil. For the time being algae EPA/DHA producers have to deal with higher production costs than their 
fish oil based EPA/DHA competitors, highly competitive pricing and a high price sensitivity among food 
industries and final consumers. In addition, PUFAs from phototrophic algae have to compete with PUFAs 
from unicellular marine heterotrophic organisms that are in the same or lower price range and contain 
higher lipid/PUFA levels. In addition, new market players have to deal with powerful food and 
pharmaceutical multinationals. Only five companies have about 75 % of the EPA/DHA market share. 
Aquaculture feed market - At the moment already more than half of the fish we consume is farmed rather 
than wild caught. This leads to an equally increasing aquaculture feed market. The main ingredient in global 
aqua feed is soybean meal followed by fish meal. Leading companies in the aqua feed sector are 
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increasingly looking at ways in which algae and other ‘alternative’ ingredients can reduce the sector’s 
dependence on fish meal (FM) and fish oil (FO). One of the market key players is now able to provide 
(approved) feed formulations with different EPA/DHA ratios from unicellular marine heterotrophic 
organisms.  
 
Livestock feed market - To feed the future world population we will have to produce much more food and 
the demand for meat and dairy is expected to increase even stronger relative to population growth. In the 
Netherlands, where several global feed market leaders are located, there is a search for feed alternatives 
as substitution for imported soya, and algae production is possible alternative for regionally produced 
protein. To be able to compete with soybean as protein source, with fish oil as PUFA source and with other 
livestock feed additives, the production price of phototrophic algae must be decreased. 
 
LCC (micro-economic) analysis  
The LCC (and LCA) focused on a potential PUFA supply chain for 2025. Two main regions were assessed 
in six scenarios: Southern Europe (Lisbon region) and Central Europe (Munich region). In addition, one 
scenario for Northern Europe (Oslo region) was added. Either a conservative 10-hectare (net) area or an 
optimistic 100 hectare (net) area was taken into account per scenario, respectively representing 
conservative and optimistic scenarios for 2025. The following strains of algae were used for the 
calculations: Prorocentrum cassubicum, Thalassiosira weissflogii (both seawater strains) and a 
combination (Algal Crop Rotation = ACR) of Chloridella simplex and Raphidonema nivale Lagerheim (both 
freshwater strains). The potential algae strains were screened during the course of the project.  
 
The LCC is therefore mainly assessing the influence of geography/climate, scale and algae strain on the 
costs of a potential mature production plant for 2025. This analysis leads to more insight whether a mature 
future PUFA supply chain based on phototrophic algae can compete with other sources of EPA/DHA. The 
capital and operational costs of all separate supply chain steps (algae production and processing, algae 
harvesting, cell disruption and drying and algae biomass processing by supercritical CO2-extraction and oil 
processing) for producing EPA/DHA from different algae strains are taken into account. This results in a 
cost price per kg EPA/DHA (functional unit). The LCC and the cost price per kg highlight the most significant 
cost items in relation to the overall production yield per strain. The LCC offers insights and options for 
improvements in the effort of the PUFA Chain to achieve a mature supply chain for 2025. 
Based on the macro-economic information the price ranges for algae or fish oil are around €400 – €1,500 
per kg EPA/DHA and algae DHA supplements for about € 5,500 per kg DHA (see macro-economic analysis, 
Chapter 2 of this report).  This price range is certainly achievable under most of the current expected mature 
production scenarios. The first conclusion is that economic viable production of PUFAs from phototrophic 
algae is feasible.  
 
The production costs represent, in all scenarios, the most important share in total costs (62-80 %). In the 
sensitivity analysis the highest production costs were taken to determine the focus for further improvements 
in the PUFAChain process. The following results were found. 
- Biomass production yield; an increase in biomass production yield translates almost directly into 
a similar cost decrease resulting in a lower cost price. This effect is similar for all scenarios. 
- CAPEX; a reduction in CAPEX for algae production of 5 % translates into around 2 % reduction 
in cost prices. This effect is slightly stronger for Munich due to higher CAPEX. 
- OPEX; a reduction in OPEX for algae production of 5 % translates into around 2 % reduction in 
cost prices. This effect is slightly stronger for Southern Europe compared to Central Europe. 
In addition, two alternative options were investigated: Firstly, locating production in cheaper more rural 
areas. All scenarios turned out to be the most expensive areas/regions for each country. Choosing a more 
rural location would significantly impact costs of land for each scenario. The second alternative option was 
related to the LCA assessment. Renewable energy, in this case solar power plants, is competitive in price 
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with fossil energy. Based on price developments of solar parks in Europe a lower price of electricity was 
assumed to be realistic. The effect of choosing a more rural location is almost 20 % for Lisbon region and 
almost 30 % for Munich region. The reduction in cost prices as a result of switching to cheaper electricity 
sources is around 8 % for Lisbon region and around 7 % for Munich region. 
 
The LCC analysis outcome shows that production in Southern Europe (Lisbon region) seems a more viable 
option compared to Central Europe (Munich region). The production of Thalassiosira at 100 ha optimistic 
scenario for Southern Europe (Lisbon region) has the best expected performance, followed by three other 
scenarios; Prorocentrum at 100 ha in Southern Europe, Thalassiosira at 100 ha in Central Europe and 
Prorocentrum at 10 ha in Southern Europe. 
 
The Algal Crop Rotation (ACR) option proved an interesting option, but was not researched to its full 
potential. The ACR scenario for Northern Europe (Oslo region) did not perform well compared to the other 
ACR options. A significantly lower biomass and EPA/DHA yield is main reason for the lower performance.  
The LCC offers insights and options for improvements in a mature supply chain for 2025. The most 
important recommendations are: 
- Investigate alternative locations with similar geographical settings, but lower land costs (e.g. 
brownfield sites or more rural locations) 
- Production equipment should be algae strain specific  
- Investigate alternative sources of energy 
- Increase both biomass production yield and PUFA content of the algae cells 
 
Socio-economic analysis 
A socio-economic evaluation was performed for aspects of (an assumed mature) PUFAChain concerning 
communities on a local level (Labour conditions (health and safety), employment opportunity, access to 
material resources and living conditions) and society in general (Consumers' health and safety, public 
commitment to sustainability issues, legal regulatory barriers and public perception). For labour conditions 
(both health and safety) no differences are expected for the different production scenarios in PUFAChain. 
Employment opportunities are expected to be more important in Southern Europe (Lisbon region) as 
opposed to Central and Northern Europe (Munich and Oslo regions). No differences are expected between 
the three regions in how algae production affects access to material resources by local populations. Living 
conditions, similar to employment opportunities are expected to improve most for Lisbon, compared to the 
other regions. This is because production in Portugal will take place in more remote areas where the 
contribution to living conditions and employment opportunities is relatively more substantial. Consumers’ 
health and safety, public commitment to sustainability issues and public perception are not expected to be 
different among the scenarios. For all scenarios in the PUFAChain however, legal regulatory barriers are 
to be expected, i.e. have to be resolved. Expectations for the different PUFAChain scenarios were 
compared to three alternative scenarios: PUFAs produced from unicellular marine heterotrophic organisms, 
from fish cuttings or from by-catch. Safety conditions for PUFAs from fish cuttings and by-catch are 
expected to be more hazardous and in these sectors less employment opportunities are expected since 
they are part of a well-developed supply chain. Unicellular marine heterotrophic organism PUFA production 
is expected to be less advantageous concerning access to material resources as there is a large demand 
for sugar production for this process which requires arable land. PUFAs from fish cuttings and by-catch are 
expected to be less advantageous to health, regarding the risk for contaminants and impurities in natural 
food chains. In addition, both processes are linked to unsustainable fisheries and therefore will trigger less 
public commitment. Regarding legislation, PUFAs from unicellular marine heterotrophic organisms are 
already authorised for feed/food/nutraceuticals, while PUFAs from fish oil are questioned regarding their 
application in infant formula. Finally, PUFAs from fish oil are linked to unsustainable fisheries, those from 
unicellular marine heterotrophic organisms to land use for sugar (food) production, while the PUFAChain 
process in theory mainly requires light and CO2.   
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SWOT analysis 
The SWOT analysis for the (assumed mature) PUFAChain is based on several micro- and macroeconomic 
factors as well as socio-economic and general sustainability issues. Environmental issues are left out of 
this SWOT analysis since they are addressed in more detail in the LCA by IFEU (Keller et al, 2017a).  
 
Strengths 
The production of omega-3 from phototrophic algae has several strong advantages compared to other 
sources of omega-3.  
• Production of pure EPA/DHA enabling tailor-made dosing 
• Production process does not contribute to pressure on wild fish stocks, is environmentally 
friendly, does not need arable land and can be labelled as vegan/vegetarian, biobased, halal, 
kosher and non-GM  
• Production can be (presumably) located in colder climates and combined with production of 
heterotrophic microorganisms.  
• EPA/DHA from PUFAChain are pure and high value products and by-products can be used for 
feed applications  
 
Weaknesses 
Weaknesses of PUFAChain consist of risks on one hand and insecurities in the development of the 
PUFAChain on the other.  
• Energy consumption for mixing may be equal to or higher than for heterotrophic production 
• PUFA production from fish oil and heterotrophic microorganisms are already mature production 
chains. This involves selection of suitable algae species, optimum growing conditions for PUFA 
production, optimum PUFA extraction from phototrophic algae biomass, optimum PUFA 
purification technologies and shelf life optimization 
• Profitability is still questionable due to productivity, difficulty of patenting, uncertain business 
plans and extensive authorization procedures 
 
Opportunities 
The present situation holds a number of opportunities for the production and marketing of omega3 from 
phototrophic algae. These include: 
• Search for PUFA alternatives due to declining fish stocks 
• Growing market demand 
• Positive image 
 
Threats 
The present situation holds a number of threats that could have a negative effect on the development of 
the PUFAChain production process. 
• New competitors producing PUFA from protists 
• More strict regulations for algae products in pharm, food and feed 
• Risk of allowance products in EU derived from GMO 
• Dropping market prices due to higher PUFA availability, increased production or decreased 
demand 
• New (negative) insights on health effects of DHA/EPA from PUFAChain 
 
Market outlook for algae based PUFAs is positive.  
The global EPA/DHA consumer market has been growing recent years and is expected to keep on growing 
in the future. The need to find new sources of EPA and DHA because of depleting wild fish stocks and 
concerns about contaminations is an opportunity for algae based PUFAs. The market segment of the aqua 
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feed is also increasingly looking in too which algae and other ‘alternative’ ingredients which can reduce the 
sector’s dependence on fish meal (FM) and fish oil (FO). 
 
The production of PUFAs from phototrophic algae is economically viable.  
A number of researched scenarios in the micro-economic assessment result in cost prices within the €400 
– €1,500 per kg EPA/DHA market price range. The market price range is based on the macro-economic 
assessment. The PUFAChain scenarios vary between the price ranges of €468 - €3,903 per kg EPA/DHA. 
The LCC analysis outcome shows that production in Southern Europe (Lisbon) seems a more viable option 
compared to Central Europe (Munich), but this will not exclude Central Europe as option overall. Within the 
researched scenarios there is potential to improve the performance even further.  
 
A mature PUFAChain should perform equal or slightly better than competing sources.  
Based on the socio-economic evaluation a PUFAChain could potentially score better on employment in 
Southern Europe scenarios and overall on food safety. PUFAs from fish cuttings and by-catch are expected 
to be less advantageous to health, regarding the risk for contaminants and impurities in natural food chains. 
In addition, both processes are linked to unsustainable fisheries and therefore will trigger less public 
commitment. PUFAs from heterotrophic microorganisms (protists) are already authorised for 
feed/food/nutraceuticals, while PUFAs from fish oil are questioned regarding their application in infant 
formula. Heterotrophic PUFA production is expected to be less advantageous concerning access to 
material resources as there is a large demand for sugar production for this process which requires arable 
land. 
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1 Introduction 
1.1 Description and goals of the PUFAChain project and work package 9 
(Sustainability) 
The overall goal of the PUFAChain project is to develop a robust scientific and technological basis for 
substantiating strategic and technical decisions for the industrial development of high-value products from 
microalgae1. The main targeted application is the use of highly purified omega-3 PUFA (polyunsaturated 
fatty acids, i.e. DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid) and SDA (stearidonic acid)) 
from microalgae as building blocks in modern oleo chemistry to gain high value products for nutrition and 
pharmaceutical applications (Figure 1). The project covers aspects of biology, cultivation technology and 
downstream technology. The project aims to realize a concrete exemplary supply chain, develop the 
technical interfaces between the different value adding stages and investigate the still open research 
aspects on every single stage while addressing the needs of the supply chain as a whole. Finally, an 
integrated processing, combining all technical steps, will be implemented for demonstration. A 
comprehensive and holistic sustainability approach will complement the scientific and commercial 
advances on each value-adding stage. Reference supply chains will be taken into account (Figure 2). 
A consortium with five companies2 and four research institutes3 will integrate state of the art science and 
technologies in order to assemble a complete process from feedstock production and harvesting to oil 
extraction and purification. Innovative technologies will be combined taking advantage of a complimentary 
partnership with the best available expertise in the sector in Europe. These processes will be evaluated for 
their sustainability and scaled-up from lab to demonstrative prototype level. 
 
 
Figure 1 Overview of PUFAChain process (From: Keller et al, 2017b) 
                                                     
1 www.pufachain.eu  
2 A4F Algafuel SA, MAHLE InnoWa GmbH, Natex Prozesstechnologie GesmbH, Cremer OLEO 
GmbH & Co. KG, EurA Consult AG 
3 Georg-August-University Goettingen, Fraunhofer IZI-BB, Wageningen Research (former 
Stichting Dienst Landbouwkundig Onderzoek (DLO)), IFEU - Institute for Energy and 
Environmental Research Heidelberg GmbH 
  
 
 
 
 
10 
  
Figure 2 PUFAChain products and reference products (From: Keller et al, 2017a) 
 
The project comprised 10 work packages (WPs) of which WP9 covers sustainability aspects (Figure 3).  
 
Figure 3 Structure of PUFAChain WP9 “Sustainability” 
 
Within WP9, IFEU carried out the WP coordination, definitions and settings description (Task 9.1) the 
environmental assessment (LCA = Life Cycle Assessment, Task 9.3) and the integrated assessment of 
sustainability (Task 9.5). Cremer OLEO GmbH & Co. KG carried out the technological assessment (Task 
9.2). Wageningen Research (former DLO) carried out the socio-economic assessment (Task 9.4), including 
a SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis. 
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Several scenarios, based on geographic location, algae species, production area and end products were 
chosen to evaluate different supply chains (Table 1).  
 
Table 1 Variables taken into account for the different supply chain scenarios 
Parameter Variables 
Geographic 
location 
Southern Europe (Lisbon), Central Europe (Munich) & Northern Europe (Oslo) 
Algae species Prorocentrum cassubicum, Thalassiosira weissflogii and a combination of Chloridella 
simplex and Raphidonema nivale Lagerheim 
Production area 10 ha, 100 ha (net area) 
End products EPA, DHA, SDA 
 
The different scenarios are explained in more detail in Chapter 3.3 (System Boundaries). Further detailed 
information can be found in PUFAChain deliverables 9.1 and 9.3. 
1.2 Objectives and methods of Task 9.4: The socio-economic assessment 
In Task 9.4 a socio-economic assessment of the systems defined in Task 9.1 was performed for the 
PUFAChain project by Wageningen Research. The socio-economic assessment includes a macro-
economic assessment (Chapter 2), a LCC (Life Cycle Costing, micro-economic) analysis (Chapter 3), 
followed by an overall SWOT analysis taking into account the different parts with emphasis on the socio-
economic aspects (Chapter 4).   
The macro-economic assessment focuses on market analysis and competiveness and provides 
information about market and price developments. Both peer-reviewed and generic data sources were 
used. The LCC (micro-economic) analysis uses both existing PUFAChain project information and tools 
in development from the Interreg project EnAlgae, combined with data from Task 9.1 and the project 
partners. UNEP/SETAC guidelines for LCC were taken into account. The macro- and micro-economic 
analyses both identify profitability and market competiveness of the systems. The SWOT analysis has 
been updated during the project and takes into account the results of the other three analyses. When useful, 
reference systems/products were assessed as well. The integrated socio-economic analysis, presented 
in a data table (Chapter 5), includes all major social and micro-economic aspects, such as impacts on 
employment and public acceptance of new technologies. Institutional, legislative and political aspects are 
included if applicable. UNEP/SETAC guidelines for sLCA (social life cycle assessment) and recent 
methodological literature are taken into account. The results are used as input for Task 9.5. 
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2 Market Analysis and Competitiveness of the PUFAChain 
By Joanneke Spruijt 
2.1 Introduction 
This chapter focuses on markets and competitiveness of the PUFAChain process. The algae in the 
PUFAChain process will be produced in industrial-scale photo bioreactors. After oil and polyunsaturated 
fatty acids (PUFA) extraction from the phototrophic algae the extraction cake can possibly be sold on 
various markets (Table 2). Main focus of the PUFAChain process is on purified eicosapentaenoic acid 
(EPA), docosahexaenoic acid (DHA) or EPA/DHA mixtures containing high EPA/DHA levels. The main 
product from the PUFAChain process is thus EPA/DHA oil from phototrophic algae and the coproduct is 
the extraction cake. In addition, after EPA/DHA purification other fatty acids (FAs) can be extracted and 
sold as coproducts, but this market is not included in the analysis. 
 
The most obvious market for EPA/DHA oil from phototrophic algae is the growing EPA/DHA consumer 
market, which can be divided into the market segments dietary supplements, pet foods, functional foods, 
infant formulas, pharmaceuticals and clinical nutrition (Table 2). Fish oil and EPA/DHA from unicellular 
marine heterotrophic organisms are the main competitors in these markets. Also, the PUFAChain process 
offers good opportunities on the growing aquaculture feed (aqua feed) market, replacing fish oil by the main 
(algae EPA/DHA) product and fish meal by the coproduct (algae oil extraction cake). Furthermore, the 
livestock feed market offers opportunities for the protein-rich algae coproduct to replace fish meal or 
soybean meal.  
 
Table 2 Products, markets and competing products of the PUFAChain process 
Product Markets Competing products 
EPA/DHA oil phototrophic algae 
(main product) 
 
EPA/DHA consumer 
market  
- Dietary 
supplements  
- Pet foods 
- Functional foods 
- Infant formulas 
- Pharmaceuticals  
- Clinical nutrition 
Aquaculture feed market 
EPA/DHA oil from heterotrophic 
microorganisms  
EPA/DHA in (concentrated) fish oil 
(FO) 
 
 
Extraction cake (coproduct)  Aquaculture feed market  
Livestock feed market 
Extraction cake from heterotrophic 
microorganisms 
Fish meal (FM) 
Soybean meal 
 
In this report, current algae, algae oil and algae EPA/DHA production, usage and cost prices are described, 
followed by the description of fish oil and fish meal production, usage and prices. EPA/DHA consumer, 
aquaculture and livestock feed markets are analysed and market opportunities, prices and positioning are 
described for the PUFAChain process.   
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2.2 Algae production  
2.2.1 Global production and usage 
There are around 30,000 species of microalgae but only a small number of them are produced on an 
industrial scale since a few decades (Gouveia et al, 2008). The most important species for biotechnological 
reasons are green algae (Chlorophycea) Chlorella vulgaris, Haematococcus pluvialis, Dunaliella salina and 
cyanobacteria Spirulina maxima. They are produced on an industrial scale mostly as human nutritional 
supplement and additives for animal feed (Table 3). According to Kovač et al (2013) Spirulina is the most 
produced species, followed by Chlorella sp., Crypthecodinium cohnii and Schizochytrium sp. The latter two 
unicellular heterotrophic marine organisms are cultivated for DHA oil.  
 
Table 3 Annual production, country of production, applications and products of algae for important species in 
descending production volume (Kovač et al, 2013) 
Algae species Annual production 
(tonnes/year) 
Producing 
countries 
Applications and 
products 
Spirulina (Arthrospira)  
 
3000 China, India,  
USA,  
Myanmar,  
Japan 
Human and animal 
nutrition,  
cosmetics   
(phycobiliproteins, 
powders,  
extracts, tablets, 
beverages,  
chips, pasta, liquid 
extract)  
Chlorella sp.  
 
2000 Taiwan,  
Germany,  
Japan 
Human nutrition, 
aquaculture,  
cosmetics       
(tablets, powders, nectar,  
noodles)  
Dunaliella salina  
 
1200 Australia,  
Israel, USA,  
China  
Human nutrition, 
cosmetics                     
(ß-carotene, powders) 
Aphanizomenon  flos- 
aquae  
 
500 USA Human nutrition                          
(capsules, crystals, 
powder)  
Haematococcus 
pluvialis  
300 USA, India,  
Israel 
Aquaculture, astaxanthin 
Crypthecodinium 
cohnii   
240 (DHA oil)   USA   DHA oil 
Schizochytrium sp. 10 (DHA oil)   USA   DHA oil 
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2.2.2 North-West European algae initiatives  
In 2012 an inventory of North-West European algae initiatives was carried out to get an overview of the 
market and research initiatives on algae production and refinery (Spruijt, 2015). Most of the 117 reported 
initiatives were found in Germany and the Netherlands, followed by France and the United Kingdom. The 
main focus is on microalgae, but especially in the UK also macro algae initiatives were mentioned. There 
is limited information about the used species. Most frequently mentioned for microalgae were Chlorella, 
cyanobacteria, Nannochloropsis, Scenedesmus and unspecified mixtures. Information about the 
production scale of algae is very limited. A lot of initiatives are at lab scale or in very small research pilots. 
In Germany and the Netherlands, only a few initiatives produce on an area larger than 250 m2 or in a volume 
larger than 75 m3. A broad range of production facilities is reported, of which the open raceway pond is the 
most frequently mentioned in an average 20 % of all cases (Table 4). In Germany (plastic) bag systems, 
flat panel bioreactors (FPBRs) and others are frequently used. In the Netherlands, algae are often cultured 
in open raceway ponds and in the United Kingdom mainly in tubular bioreactors or in the sea (Spruijt, 2015). 
 
Table 4 Production modes as percentage of total North-West European algae initiatives (117) per country and as 
percentage of all initiatives (Spruijt, 2015). Some initiatives employ multiple production modes  
 DE NL FR UK All 
Open raceway pond 11 50 9 0 20 
Tubular bioreactor 14 17 4 25 15 
(Plastic) bag system 19 6 0 6 9 
Flat panel bioreactor 16 0 0 6 6 
Wild seaweed 0 0 0 19 3 
Other 19 6 9 13 13 
Unknown 22 31 87 31 39 
 
Many initiatives are using waste or residual streams to produce algae for one or more algae markets. 
Examples of these streams are CO2, manure and industrial or municipal waste streams.  Since production 
costs are lowered by using these waste streams, waste stream handling can be seen as a market sector. 
Waste stream and energy markets are most frequently mentioned. These markets have the lowest added 
value (Figure 4). High value molecules constitute the top of the market in added value. A lot of initiatives 
are focussed on this market (Spruijt, 2015) (Table 5).  
 
 
  
 
 
 
 
15 
 
Figure 4 Number of North-West European algae initiatives in the algae market value pyramid (Spruijt, 2015) 
 
Table 5 Market focuses as percentage of total North-West European algae initiatives per country and as 
percentage of all initiatives (Spruijt, 2015). Some initiatives focus on multiple markets 
 DE  NL FR UK All 
Waste stream 43 42 4 19 31 
Energy 51 6 48 0 29 
Feed 16 42 9 31 26 
High value molecules 16 8 48 19 22 
Food 24 6 13 13 15 
Technology provider 14 3 9 0 8 
Chemical oils 8 0 0 0 3 
Fertilizers 0 0 4 19 3 
Provider of culture material 3 0 4 0 2 
Others 0 0 0 6 2 
Unknown 8 33 13 31 20 
 
In Germany the majority of the initiatives are pilots or research projects. The research is very diverse, from 
screening algae species, research on cyanobacteria and optimizing photo bioreactors (PBRs) to the 
production of high value molecules, biogas and hydrogen. Only a minor share of the initiatives are assumed 
to be commercially active selling algae products or services. Three of them are technology providers, from 
which two also serve algae product markets. German initiatives mainly handle waste streams and/or 
produce feed/food products. Two of them produce high value molecules. Also in the Netherlands most of 
the initiatives are pilots or research projects. Scientific organisations are less often involved than in 
Germany. Pilots often concern waste stream handling from agricultural, industrial, domestic/municipal and 
transport sectors. Four initiatives are producing (shell) fish feed, two of them are pilots. Only about five 
organisations are commercially selling algae products or technologies. French companies are mainly active 
in the high value molecule market (especially in France: cosmetic products) or in the low value energy 
market. There is hardly any information available on the status or scale of these initiatives. In French 
research projects the energy market is also important. In the United Kingdom and Ireland, more activities 
involve macro algae (7 out of 17 initiatives). All of them are private companies. Microalgae are used to 
produce fertilizers, feed additives, food, cosmetics, and high value molecules or to filter out microalgae from 
ecologically sensitive areas. Two Belgian projects were reported on pilot-scale. They are producing for the 
high value market or other markets. One project in Belgium covers a hectare. In this project CO2 is captured 
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from the lime and glass industry to produce biofuel for industrial furnaces and reduction of fuel energy 
consumption (Spruijt, 2015). 
2.2.3 Cultivation systems 
2.2.3.1 Phototrophic algae production systems 
Large-scale cultivation of microalgae for human and animal nutrition takes place since decades in open 
ponds/raceways4. For producing more specific products, closed PBRs are used increasingly. PBRs come 
as simple or complex transparent tubes, panels and bags in different configurations. They make controlled 
and reproducible high-density growth of microalgae possible. Economic aspects concerning micro-algae 
production systems were studied on the basis of bio-economic models by Spruijt et al (2014a). Three types 
of micro-algae production systems were studied: open ponds, tubular and flat panel bioreactors (FPBs).  
 
The yearly algae biomass production in a 1,000 m2 open pond located in the Netherlands is 1,538 kg of dry 
matter (DM) according to the model, equalling 15 tonnes DM per ha. Biomass productions per area in 
tubular and flat panel PBRs are twice and more than three times higher than in an open pond respectively 
(Figure 5). Differences in production between production systems could be attributed fully to differences in 
photosynthetic efficiency (PE) on daylight (1.5 %/3 %/ 5 % respectively for the three systems) dependent 
on system configuration (light path) according to Spruijt et al (2014a). 
 
 
Figure 5 Yearly biomass production in kg DM for three algae production systems (1,000 m2 scale) (Spruijt et al, 
2014a) 
2.2.3.2 Unicellular marine heterotrophic organisms production systems 
The unicellular marine heterotrophic organism production in fermenters results in higher biomass growth 
rates, higher cell densities and as a result improved harvesting compared to phototrophic algae production. 
In these systems, organic carbon is the energy source and O2 is a limiting factor for growth. Fermenter 
sizes range from 1 to 500,000 litres5. The technology is decade’s old and commercial fermenters are readily 
available. A typical fermenter size is 200,000 L (Lee Chang et al, 2015). Glucose is the most widely used 
source of organic carbon and is relatively inexpensive, around 0.50 € per kg. However, 2-3 kg glucose is 
needed to produce one kg of algae biomass (DM) (Orfield et al, 2015). Zheng (2013) shows a comparison 
of microalgae production in phototrophic and heterotrophic systems (Table 6).  
  
                                                     
4 http://www.enalgae.eu/growth-and-harvesting.htm  
5 www.bbi-biotech.com  
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Table 6 Comparison of phototrophic and heterotrophic microalgae biomass production methods (Zheng, 2013) 
Variable Raceway pond PBR Heterotrophy 
Microalgae biomass (tonnes DM) 100 100 100 
Volumetric productivity (kg/m3/day) 0.08 1.5 24.2 
Area (m2) 12,121 6,313 200 
CO2 (tonnes) 183 183 -129 
Sugar (tonnes) - - 213 
Water (MM gal) 7.3 2.2 0.2 
2.2.4 Cost price algae biomass 
2.2.4.1 Phototrophic algae 
According to Spruijt et al (2014a) the cost price for algae biomass produced on the reference scale of 1,000 
m2 is much lower in PBRs than in open ponds, mainly because of the lower costs for capital goods and 
labour (Figure 6). Only electricity costs were slightly higher for PBRs. The use of flat panel PBRs resulted 
in the lowest algae biomass cost price. It should be noted that CO2 and heat supply were supposed to be 
available at no costs in their model. Norsker et al (2011) calculated an ascending cost price for tubular 
PBRs, open ponds and flat panel PBRs of 4.15, 4.95, and 5.96 € per kg DM respectively on 100 ha scale, 
including dewatering. On 1 ha scale the cost prices were 9.90, 17.72, and 10.49 € per kg DM respectively, 
which means their calculations for open ponds were significantly different from the model by Spruijt et al 
(2014a).  
 
Figure 6 Algae cost price per kg DM for three algae production systems at 1,000 m2 scale. Productivities for the three 
systems are estimated at 15, 31 and 51 tonnes DM per ha respectively for open ponds, tubular PBRs and flat panel 
PBRs (Spruijt et al, 2014a) 
 
Economies of scale of algae production for tubular PBRs were explored as well by Spruijt et al (2014a) 
(Figure 7). The cost price for algae biomass in these systems ranges from 19.07 €/kg DM at small scale 
(Figure 6, this equals around 3 tonnes DM per year) to 4.57 €/kg DM at large scale (Figure 7, this equals 
around 3,000 tonnes DM per year). Even at the largest scale costs remained high due to electricity costs.  
 
.  
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Figure 7 Algae cost price per kg DM in tubular PBRs at ascending scale (Spruijt et al, 2014a) 
More recently, Ruiz et al (2016) calculated the cost price for 100 ha facilities in six locations. The lowest 
price was found for the south of Spain (3.40 €/kg DM) in flat panel photo bioreactors. They expect prices 
to go down to around 0.50 €/kg DM for that location in ten years.  
2.2.4.2 Unicellular marine heterotrophic organisms  
The heterotrophic microorganism production has advantages compared to phototrophic production like the 
use of (relatively) proven technology (fermenters have been used for decades in biotechnological 
industries), higher biomass growth rates and higher oil and PUFA contents of the cells. As mentioned, 
glucose represents a major share of the costs: 1 kg of algae DM biomass requires input of 2-3 kg of glucose 
(Orfield et al, 2015). In addition, cooling costs (fermentation of sugar leads to heat production) and electricity 
costs (aeration, stirring, sterilization etc.) represent important costs. The use of alternative low-cost carbon 
sources may lead to decreases in cost price (Zheng, 2013), but this technology is not used on an industrial 
scale as the major algae producers use sugar from cane or corn. Zheng (2013) calculated a cost price of 
0.39 € per kg DM in a system with a yearly production of 100 tonnes DM with lignocellulose materials as 
the feedstock. He did not include costs for electricity as they were assumed to be compensated for by the 
provided energy from burning organic by-product streams from the process in an ethanol plant. In addition, 
their yearly capital depreciation of 5,800 € for a plant that can produce 100 tonnes of DM seems extremely 
low.  
 
Sijtsma calculated that DHA from heterotrophic microorganism C. cohnii, grown on ethanol, was 3-5 times 
more expensive than DHA from fish oil. Perez-Garcia and Bashan (2015) present conservative and 
optimized cost prices of 4.50 and 0.45 €/kg for phototrophic and 1.25 and 1.05 €/kg for heterotrophic 
production respectively based on Wijffels et al (2010) and Tabernero et al (2012). The prices for 
phototrophic production are based on a production area of 100 ha flat panel PBRs, while those for 
heterotrophic production are based on 465 fermenters of 150,000 L each. As a kg of glucose costs about 
0.71 €/kg (Zhao et al, 2015), the minimum substrate cost price for a kg DM microalga is at least 1.42 €. 
Equipment costs of fermenters are assumed to be cheaper than those of PBRs (Perez-Garcia and Bashan, 
2015), but equipment costs for comparable systems are high (Table 7). Depreciation times influence 
equipment costs to a large extent. Tabernero et al (2012) for example assumed a depreciation time of 35 
years, which can explain the low resulting cost price.  
 
Estimates by Huurman and Elissen (personal communication, 2017) on heterotrophic biomass cost price 
considered energy consumption, glucose and mineral nutrients consumption and the use of comparable 
reactor systems. This resulted in a cost price range of 3.14-9.15 €/kg DM heterotrophic microorganisms 
(Table 7). 
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Table 7 Optimized and conservative cost prices for heterotrophic microorganism biomass and EPA/DHA oil 
(Huurman and Elissen, personal communication, 2017) 
 Optimized  Conservative  
 Per kg DM Per kg*** EPA/DHA 
oil 
Per kg DM Per kg*** EPA/DHA 
oil 
Energy 0.89 3.54* 0.89 5.53* 
Glucose 1.42* 5.68* 2.13* 13.31* 
Mineral nutrients 0.17 0.70* 0.17 1.09* 
Equipment (USP and 
DSP) 
0.66 2.66** 5.96 23.83** 
Total 3.14 12.57 9.15 43.76 
*Assuming 50 % oil/ 50 % EPA/DHA/ 2:1 glucose to biomass conversion and 40 % oil / 40 % EPA/DHA/ 3:1 glucose biomass conversion respectively in 
optimized and conservative scenarios 
** Assuming only 50 % oil/ 50 % EPA/DHA scenario, as equipment costs are highly variable 
*** The density of EPA/DHA is 0.943 g/cm3 
 
The main variable (due to system complexity and requirements and surrounding logistics) is the price of 
equipment, including production facilities and centrifuging equipment (USP and DSP) (Petrides, 2000; 
Meyer et al, 2017). A depreciation time of 10 years was assumed. The calculations were based on seven 
fermenters of each 260,000 L total volume (filling volume of each reactor is 200,000 L), producing 8,400 
tonnes DM heterotrophic microorganisms biomass per year. Overall, equipment costs and glucose seem 
to be the most important drivers of heterotrophic cost price, followed by energy (e.g. for mixing, aerating, 
sterilization and cooling) and mineral nutrients. Of course, energy and glucose costs could be lowered by 
the use of waste streams with co-generation of energy.  
2.2.4.3 Cost price comparison 
Based on the optimized rough cost price estimate (Table 7) and Figure 7 at comparable production scales, 
heterotrophic production seems cheaper than phototrophic production in tubular PBRs (€3.14 vs. €4.57 per 
kg DM Biomass). Considering the higher oil and EPA/DHA content of heterotrophic microorganisms, the 
difference in cost price per kg of EPA/DHA oil even increases in favour of heterotrophic production. With 
improving technologies and efficiency and increased use of low-cost substrates, cost prices for both types 
of microorganism/-algae are expected to decrease further. According to Chauton et al (2015) optimized 
costs for EPA or DHA production can be €10.41 per kg PUFA from flat panel PBRs (assuming optimized 
photosynthetic efficiency and doubling of the EPA and DHA yield of phototrophic algae).  
2.3 Algae oil production 
2.3.1 Global production and usage  
Algae oil is almost exclusively produced for PUFAs. In 2014, global production of omega-3 algae oils was 
approximately 7,280 tonnes6. Many pilot systems have been built to produce biodiesel from algae, but they 
were not economically viable.  
2.3.2 Downstream processing of algae into oil 
Downstream processing (DSP) of algae into oil in the EnAlgae model (Spruijt et al, 2014a) involves the 
recovery of intracellular lipids, and the subsequent conversion to fatty acid methyl esters (FAME) via a 
transesterification reaction. Steps involved in this process are: 
                                                     
6 https://www.naturalproductsinsider.com/articles/2015/03/omega-3-insights-magazine-
algal-based-omega-3s.aspx  
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2.3.2.1 Drying 
Dry biomass is preferable for supercritical CO2 (sCO2) extraction, as the presence of water can create a 
boundary layer, making it more difficult to extract lipids. 
2.3.2.2 Milling 
Breaking open cell walls will enhance extraction of intracellular contents such as neutral lipids. In this step, 
a ball mill is used for mechanical cell disruption. 
2.3.2.3 Supercritical CO2 extraction (sCO2) 
In the supercritical CO2 process step CO2 is passed through a sub-cooler to become liquid so it can be 
pumped towards the vessel containing the algae biomass. The temperature and pressure are raised to 
enable the CO2 to become supercritical. CO2 acts as a solvent to remove neutral lipids, such as 
triacylglycerides (TAG). A pressure drop is used to collect various fractions from the biomass. The model 
simplifies the process by examining the extraction of only one product (TAG) from the algae biomass. In 
practice, other products such as pigments could be extracted simultaneously, and a second 
depressurisation step added to collect a different fraction. Following sCO2 extraction, the remaining 
(protein-rich) biomass can be sold for other purposes. 
2.3.2.4 Refining 
Lipid material extracted from algae biomass must be refined prior to transesterification, to exclude any 
membrane lipids and chlorophyll from the TAG. Lipids are refined using methanol and a catalyst. The use 
of methanol is taken from Spruijt et al, 2014a, which is not suitable for example for nutraceutical 
applications. 
2.3.2.5 Transesterification 
In the model (Spruijt et al, 2014a), base catalysed (using potassium hydroxide) transesterification is used. 
Methanol must be present in excess as the reaction between the alcohol and lipid is reversible. A 98 % 
conversion of TAG to FAME is assumed. Glycerol, which is a by-product of the transesterification reaction, 
could be purified and sold. 
 
The main DSP costs are supercritical CO2 extraction, drying and milling, although by-products (protein-rich 
biomass and glycerol) could generate some extra revenues. Economies of scale are also of interest, as 
shown in Figure 8. 
 
 
Figure 8 Downstream processing costs per litre algae oil at two scale levels (Spruijt et al, 2014a) 
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2.3.2.6 Revenues from DSP by-products 
Protein-rich biomass 
De-fatted biomass from sCO2 extraction could have a number of applications. As a source of protein, it 
could be a substitute for soybean meal. According to the EnAlgae DSP model (Spruijt et al, 2014a) every 
litre algae oil results in around 3.8 kg de-fatted protein rich algae biomass, with a 62.5 % protein content. 
Soybean meal prices are 250-450 € per tonne. Based on an average soybean meal price of 0.35 €/kg (50 
% protein content) the selling price for defatted algae biomass is assumed to be 0.44 €/kg (Spruijt et al, 
2014a). Algae biomass with a residual amount of omega-3 lipids could be more valuable, with a market 
price more similar to fish meal (currently priced at >1 €/kg7). In Chapter 3.4.3 also a polysaccharide-rich 
by-product is described, but this is not taken into account in the calculations shown in Table 8.  
 
Glycerol 
Glycerol is a by-product of the transesterification reaction. The crude product may contain water, free fatty 
acids and residual salts. Distillation may be carried out to produce a purer product, and as such increase 
the value. Pure glycerol has applications in the pharmaceutical and personal care industries. A crude 
glycerol product may be used as an additive to anaerobic digestion to enhance biogas yield. In the EnAlgae 
DSP model, subsequent refining of the glycerol is not considered. Every litre algae oil results in the 
production of 91 grams glycerol with a price similar to that of crude glycerol (0.50 € /kg) (Spruijt et al, 
2014a). Revenues from DSP by-products protein-rich biomass and glycerol are thus assumed to be 1.68 
and 0.05 €/l algae oil respectively (Table 8) (Spruijt et al, 2014a). 
 
Table 8 Revenues from DSP by-products per litre algae oil (Spruijt et al, 2014a) 
By-product Amount Unit price Revenues 
Protein-rich 
biomass 
3.844 kg DM 0.44 €/kg DM € 1.68 
Glycerol 0.091 kg 0.50  €/kg € 0.05 
Total      € 1.73 
 
When subtracting these revenues from the costs (Figure 8) this leads to net cost prices for algae oil of 
21.91 and 1.83 € at small and large scale respectively.  
2.3.3 Cost price algae oil 
The calculated cost price for algae oil in the EnAlgae bio-economic production models ranges from 69 €/L 
at small scale to 26 €/L at large scale (Spruijt et al, 2014a). Small scale is based on yearly production of 
2,107 L algae oil from 10 tonnes DM algae at an assumed cost price of €10 per kg DM with DSP costs of 
21.91 €/L. Large scale is based on yearly production of 300,000 L algae oil from 1,500 tonnes DM algae at 
decreased cost price of €5 per kg DM with DSP costs of 1.83 €/L. The algae biomass cost is the main driver 
for the production price. For heterotrophic microorganisms, lipid content is about 2.5 times as high as for 
phototrophic algae (50 % vs. 20 %) (Spruijt et al, 2014a; Orfield et al, 2015). This possibly affects DSP 
costs.  
                                                     
7 www.indexmundi.com  
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2.4 EPA/DHA production from microalgae 
The lipid content of microalgae varies between 1 and 85 % of DM with typical contents of higher than 40 % 
under environmental stress conditions (Chisti, 2007). PUFAs like EPA and DHA have beneficial health 
effects, comparable to the effects of fish oil (Becker, 2013).  
2.4.1 EPA/DHA global production and usage  
The global market value for omega-3 oils was around 320 million € in 20148. Infant formula applications 
represent the most important end application for DHA oil (about 49 % of the volume in 2012), followed by 
dietary supplements (28 %), food and beverage (19 %) and animal feed (about 4 %) (Figure 9)9.  
 
 
Figure 9 Global algae DHA market volume by end application in 20126 
2.4.2 EPA/DHA producers 
DSM/Evonik 
The former Martek Biosciences Corporation, now part of DSM, is a major producer of PUFA from algae6. 
They produce algae oils from heterotrophic microorganism Schizochytrium sp., for example Life’sDHA™ 
and Life'sOMEGA™ (Figure 10). The algae oil contains 50 % EPA/DHA (DSM/Evonik, 2017). This PUFA 
source will be aimed at initial applications in salmon aquaculture and pet food and is produced in the US10. 
  
                                                     
8 https://www.naturalproductsinsider.com/articles/2015/03/omega-3-insights-magazine-
algal-based-omega-3s.aspx  
9 http://www.algaeindustrymagazine.com/the-global-algae-oil-omega-3-market-in-2014/  
10 http://www.feednavigator.com/R-D/Skretting-gets-behind-algal-oil-breakthrough-from-
Evonik-and-DSM?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright  
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Figure 10 Martek Biosciences Corporations fermentation vessels for heterotrophic microorganism production (Ismail, 
2013) 
 
Lonza  
Lonza is an ingredient manufacturer like DSM. The company lost a patent dispute with Martek/DSM about 
algae DHA and DSM currently supplies Lonza11. They sell DHA (‘DHAid’) as oil and powder ingredient for 
the food industry from the same heterotrophic microorganism source as DSM 12 . DHAid is a refined 
triacylglycerol oil (>95% TAG), derived from Ulkenia sp., a marine protist, with a total DHA content of 38 to 
50 %. The remaining fatty acids of Ulkenia DHA oil are comprised mainly of saturated palmitic acid (C16:0) 
(28 to 37 %) and a lesser amount (8 to 14 %) of the omega-6 fatty acid docosapentaenoic acid (DPA) 
(C22:5) (GRAS Notice 319). 
 
Source-Omega 
Source-Omega uses heterotrophic technology and water extraction to produce its DHA algae oil from 
Schizochytrium algae13. 
 
Qualitas Health 
Qualitas Health has ‘Almega PL’ on the market, an EPA-rich algae strain for dietary supplements, 
photographically grown in open ponds14 (Figure 11). It is an omega-3 oil from Nannochloropsis oculata 
marketed as an alternative to krill oil. The strain has a polar lipid structure, including glycolipids and 
phospholipids, which enhances bioavailability.  
 
                                                     
11 http://www.nutraingredients.com/Suppliers2/Lonza-and-DSM-settle-omega-3-patent-
dispute  
12 http://www.nutritionaloutlook.com/delivery-systems/everywhere-omega-fatty-acids 
13 www.source-omega.com  
14 www.qualitas-health.com  
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Figure 11 Open pond system Qualitas Health10  
 
SB oils  
Solazyme Bunge Renewable Oils (SB oils) is a joint venture between TerraVia and Bunge, which produce 
‘AlgaPrime DHA’, a whole algae ingredient for the aquaculture feed market (Figure 12). Table 9 shows the 
basic nutritional and fatty acid profile of AlgaPrima DHA11. The facility is based in Brazil and the 
Schizochytrium algae producing DHA rich oil are grown on sugar cane. The sugarcane waste is a 
renewable source of energy for the facility15. 
 
Figure 12  Scheme of the SB Oils facility11  
  
                                                     
15 www.algaprime.com  
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Table 9 Basic nutritional and fatty acid profile of AlgaPrime DHA11  
Basic nutritional profile        Content (g/100g) Fatty acid profile              FA as % of fat 
 
Protein (crude) 12.6 C16:0 (Palmitic)  33.8 
Moisture 3.0 C18:0 (Stearic) 1.5 
Ash 14.0 C22:5 n6 (DPA)   12.6 
Carbohydrates 12.0 C22:6 n3 (DHA) 48.2 
Fat 53.0   
Fibre (crude) 5.4   
 
Cellana 
This company patented their algae cultivation system ‘ALDUO’ whereby series of photo bioreactors are 
coupled with open ponds (Figure 13). Cellana has a pilot project in Hawaii where marine microalgae are 
grown and EPA and DHA containing products are sold. Cellana’s ‘ReNew’ product line is focused on high 
value oils for human nutrition and whole algae enriched with EPA/DHA for animal and aquaculture feeds16. 
 
 
Figure 13 Cellana’s ALDUO system: photo bioreactors coupled with open ponds12  
 
Aurora Algae 
Aurora (as the former Aurora Biofuels) tried to set up a large scale open pond algae project in Western- 
Australia to produce biodiesel, but the project proved unprofitable17,18. In 2014, Aurora (as Aurora Algae) 
bought land in South-Texas to cultivate phototrophic algae strains in open seawater ponds with a high EPA 
content (Figure 14). This project seems to have failed as well, because the company sold off the Texas-
based land and the lab equipment in 2015. 
 
                                                     
16 www.cellana.com  
17 http://www.biofuelsdigest.com/bdigest/2015/07/22/rip-aurora-algae-algae-and-the-
never-never/  
18 http://www.biodieselmagazine.com/articles/8012/aurora-algae-lands-22-million-in-
finance-round  
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Figure 14 Open pond system Aurora Algae in Western Australia14  
 
Algae Biosciences 
Algae Biosciences stated to use a closed PBR (Figure 15) and supercritical CO2 extraction, as opposed to 
some competitors that employ hexane or other hydrocarbon-based solvents. They grew two different strains 
of marine algae separately, extracted the EPA and DHA separately, and blended them in one product, 
according to customer wishes19. However, there is no company website anymore.  
 
Figure 15 PBR system (Ismail, 2013) 
 
AlgaeCytes 
The British company AlgaeCytes is developing and commercialising ingredients and focuses on EPA and 
high protein biomass from freshwater microalgae20. They produce EPA rich (30 % EPA of total FAs) algae 
oils from Eustigamatophyte freshwater microalgae (Figure 16). 
 
                                                     
19 http://www.nutritionaloutlook.com/delivery-systems/everywhere-omega-fatty-acids  
20 www.nutramara.ie  
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Figure 16 AlgaeCytes pilot installations16  
 
BASF and NPC 
BASF and NPC started a partnership in 2013 to join forces on algae technology21. Their systems for marine 
algae are based on constructed lakes for prawn production in Saudi-Arabia.   
 
Fraunhofer IGB 
Researchers at the Fraunhofer IGB institute, Germany, grow the marine phototrophic microalgae 
Phaeodactylum tricornutum for EPA production in a PBR, flat-panel airlift (FPA) reactor22.  
Table 10 shows an overview of the different algae EPA/DHA producers mentioned.  
  
                                                     
21 www.newtrition.basf.com  
22 http://publica.fraunhofer.de/documents/N-45331.html  
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Table 10 Overview of algae EPA/DHA producers, algae strains, technologies/activities and markets 
Company Algae strain Cultivation 
system 
Marketing or 
developing 
Market focus 
Algae 
Biosciences 
One EPA and one DHA 
strain? 
Phototrophic 
PBR’s 
Developing DHA and EPA (separately) 
consumer market 
AlgaeCytes Eustigamatophyte 
freshwater microalgae 
Phototrophic  
flat panel 
bioreactors? 
Developing EPA consumer market 
Aurora Algae High EPA marine strain? Phototrophic  
open ponds 
Stopped EPA consumer market 
BASF and 
NPC 
Marine algae? Phototrophic 
Open ponds? 
Developing Consumer and aquaculture feed 
market? 
Cellana Marine algae? Phototrophic  
open pond/PBR 
combi 
Marketing/developing DHA and EPA consumer and 
animal/aquaculture feed market 
DSM/Evonik Crypthecodinium cohnii and 
Schizochytrium sp. 
Heterotrophic 
on sugar 
Market leader DHA and EPA consumer market 
Fraunhofer 
IGB 
Phaeodactylum tricornutum Phototrophic  
flat-panel PBR 
Developing EPA 
industrial market 
Lonza Crypthecodinium cohnii and 
Schizochytrium sp.? 
Heterotrophic 
on sugar 
Marketing DHA consumer market 
SB oils Schizochytrium sp. Heterotrophic 
on sugar 
Marketing Whole algae DHA aquaculture 
feed market 
Source-
Omega 
Schizochytrium sp. Heterotrophic 
on sugar 
Marketing DHA consumer market 
Qualitas 
Health 
Nannochloropsis oculata Phototrophic  
open ponds 
Marketing EPA consumer market 
2.4.3 EPA/DHA purification 
Algal EPA/DHA purification is a complex process and depends on the algae strain used. The following 
techniques were found in literature. In PUFAChain short-path distillation is used in Work Packages 5 and 
6. 
2.4.3.1 Winterization and urea complexation 
Mendes et al (2007) developed a simple and inexpensive procedure for concentrating DHA from C. cohnii 
biomass. This involved saponification and methylation in wet biomass, winterization and urea complexation. 
Temperature had a significant effect on DHA concentration and they found the most concentrated DHA 
fraction (99.2 % of total FAs) at a urea/fatty acid ratio of 3.5 and crystallization temperatures of 4 and 8 °C. 
The highest DHA recovery (49.9 %) was found at a urea/fatty acid ratio of 4.0 and a crystallization 
temperature of 24 °C, which corresponds to 89.4 % DHA of total FAs.  
2.4.3.2 SMB Technology 
Orochem developed the Simulated Moving Bed technology23. They can purify up to 97-99 % EPA, DHA 
and ALA (α-linoleic acid) from different feedstock with EPA and DHA percentages lower than 20 % by using 
an absorbent.  
2.5 Fish meal and fish oil (FM and FO)  
2.5.1 FM and FO production 
According to IFFO, 75 % of fish meal and fish oil is produced from small fish species (anchovy, herring, 
capelin and menhaden) that are not often used for human consumption due to little demand or 
                                                     
23 www.orochem.com  
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infrastructure24. The other 25 % is produced from fish offal, trimmings or cuttings, and other wastes from 
processing of edible fish. In 2010 fish oil and fish meal production were respectively 888 and 4,166 
thousand tonnes (Figure 17) (Shepherd & Jackson, 2012). The raw fish are cooked, pressed, dried and 
ground. From pressing a liquor is produced, that contains fish oil, water and soluble protein. The oil is 
recovered by centrifugation and further refined. The solid fraction after drying and grounding is fishmeal 
with on average 6-10 % fish oil. The largest fish meal producers are Peru and Chile, followed by   
Thailand, China, USA, Japan, Denmark, Norway and Iceland20.  .  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Mass balance of marine ingredients production in 2010 (From: Shepherd & Jackson, 2012) 
 
 
Figure 18 Global fish meal and fish oil production 1964-2010 (From: Shepherd & Jackson, 2012) 
 
The fish meal and fish oil production varies from year to year and decreases during the El Niño phenomenon 
every couple of years (Figure 18) (Shepherd & Jackson, 2012). In addition, due to limited fish supplies and 
increasing demand, the sector is vulnerable. It is estimated by FAO that 90 % of the world’s fisheries are 
fully exploited or facing collapse25. Both fish meal and fish oil supplies have been decreasing the last years 
                                                     
24 http://www.iffo.net/production  
25 https://www.nytimes.com/2017/04/30/world/asia/chinas-appetite-pushes-fisheries-to-
the-brink.html  
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26. Possible alternatives are trimmings from processing factories, vegetable oil and meal, insects, single-
cell protein, recycled waste and algae. It is expected that alternatives are becoming more and more 
important 27.  
2.5.2 FM and FO usage  
In the 1960s fish meal (68-72 % protein and 6-12 % oil) was almost exclusively used as a high protein 
ingredient in nutritionally demanding periods in the life cycles of pigs and poultry (Figure 19)28. Currently 
the main use is high protein feed ingredient in aquaculture (Shepherd & Jackson, 2012).
 
Figure 19 Changing uses of fish meal from 1960 to 2010 (From: Shepherd & Jackson, 2012) 
 
In the 1960s fish oil was mainly used as hardened edible oil and for industrial uses. Currently most fish oil 
is used aquaculture feeds and increasingly for human nutritional supplements and functional foods (Figure 
20) (Shepherd & Jackson, 2012).  
  
                                                     
26 https://www.undercurrentnews.com/2015/03/09/iffo-global-fishmeal-fish-oil-supply-
could-return-to-normal-levels-in-2015/  
27 http://www.luxresearchinc.com/news-and-events/press-releases/read/alternative-
proteins-claim-third-market-2054  
28 www.iffo.net  
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Figure 20 Changing uses of fish oil from 1960 to 2010 (From: Shepherd & Jackson, 2012) 
2.5.3 FM and FO price 
Because of the limited supply sources, the fish meal and oil sector remains vulnerable. Prices are, as 
mentioned, influenced by the El Niño seasons and the extent to which alternative sources are available. 
From 2011-2015 (Figure 21) fish oil prices varied from €1.07 to €2.14 per kg (€1.21 to €2.43). Nikolik and 
de Jong (2017) expect the fish meal and fish oil prices to stabilize the coming years due to a stabilizing 
supply.  
 
 
Figure 21 Fish oil and fish meal price developments in Europe, 2011-2015 (FAO, 2016) 
2.5.4 FO EPA/DHA purification 
Fish oil can contain environmental pollutants (Tocher, 2009) and ingredients with a fishy smell/taste, which 
are difficult to remove as each step reduces the quality of EHA/DPA. Purification of PUFA from fish oil can 
for example be done by multicolumn counter current solvent gradient purification (MCSGP) or silver-thiolate 
chromatographic material and high-performance liquid chromatography (Dillon et al, 2013). No information 
has been found about the costs of these processes. 
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2.6 EPA/DHA consumer market  
2.6.1 PUFA health claims 
PUFAs (EPA, DHA and ALA) protect against heart disease and fit into a healthy diet29, 30. High levels of 
EPA and DHA are present in fatty fish, such as mackerel, herring and salmon. An average content of EPA 
and DHA is found in perch, shrimp, cod, mussels, lobster and haddock. Fish cannot make their own DHA 
and EPA, but obtain them from algae. ALA is a vegetable fatty acid, found in (wal)nut, linseed oil and other 
vegetable oils. The human body can also make EPA and DHA to a small extent itself from ALA. The 
European Food Safety Authority (EFSA) has approved health claims on omega-3 fatty acids31. DHA/EPA 
are important for maintenance of normal cardiac function and normal (fasting) blood concentrations of 
triglycerides. DHA is important for maintenance of normal vision and normal brain function, ALA for 
contribution to brain development (Table 11). In contrast, there are also concerns about an increased risk 
for prostate cancer32. 
 
Table 11 EFSA approved health claims for DHA, EPA and ALA25 
Claims DHA/EPA DHA ALA 
Maintenance of normal cardiac function X   
Maintenance of normal (fasting) blood concentrations of triglycerides X   
Maintenance of normal vision  X  
Maintenance of normal brain function  X  
Contribution to brain development   X 
 
2.6.2 Global EPA/DHA market development 
The global EPA/DHA market is growing fast33. In 2013, the market was estimated to be 124 thousand 
tonnes worth almost 2 billion € and is predicted to be 241 thousand tonnes valued at 4.2 billion € by 2020. 
Positive results on health effects combined with approved health claims, increased health awareness and 
a higher living standard are important drivers for this market. Negative impacts on the market growth (of 
fish oil) are fear of overfishing/depleting fish supplies and concerns about contaminations or negative health 
effects.   
2.6.3 Market developments by (oil) source 
The largest part of the EPA/DHA oil market volume and value is from fish and only a minor part from algae 
(Figure 22A). Algae oils have a relatively larger share in market value (18 %) than in market volume (Figure 
22B). Because of the depleting fish supplies (mainly anchovy: see below), krill and algae are expected to 
be the most promising sources of raw material in the near future 34. As mentioned in chapter 2.5.1, due to 
limited fish supplies and increasing demand, the sector is vulnerable. It is expected that fisheries cannot 
be sustainably extended to a substantial degree to meet additional market demand. It is even concluded 
that both fish meal and fish oil supplies have been decreasing the last few years. 
 
                                                     
29 https://www.hartstichting.nl/gezond-leven/vetten  
30 www.voedingscentrum.nl/encyclopedie/omega-3  
31 https://www.efsa.europa.eu/en/press/news/120727  
32 http://www.harvardprostateknowledge.org/high-intake-of-omega-3-fats-linked-to-
increased-prostate-cancer-risk  
33 http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs-
A-Global-Market-Overview.html  
34 https://www.gminsights.com/industry-analysis/EPA-DHA-omega-3-ingredients-market  
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A     B 
Figure 22 EPA/DHA market volume (A) and value in 2011 (B) by source (35; Ismail, 2013) 
2.6.3.1 Fish oil 
Most fish oil is produced in Peru, Chile, Scandinavia and other European countries, adding up to 85 % of 
the global production in 201436. Due to its high EPA and DHA content and well-regulated fisheries, anchovy 
oil is the most used29. In 2014 however, there was a reduced capture of anchovy due to concerns over 
remaining stocks (Bernasconi, 2014). As mentioned, concerns over declining fish stocks, contaminations 
and taste aspects make alternative oils more attractive. Technological advances allow better 
(micro)encapsulation (taste masking) of omega-3 ingredients, resulting in a broader usage scope in the 
food and beverage industries. This however doubles the price of the product (D. Lochmann, personal 
communication, 2016).  
 
Fish oil concentrates, because of their high prices in pharmaceutical applications, have the highest market 
share: 48 % of the EPA/DHA market value in 2014. In the three largest markets (US, Europe and China) 
increasingly consumers prefer concentrates over refined anchovy oils. As a result, the global demand 
increased with 3 % but a concomitant sharp decline in prices resulting from increased competition led to 
an overall decrease in the value of the concentrate market of 7 % (Bernasconi, 2014). Concentrates are 
increasingly popular because they result in a lower daily intake in number of pills and avoidance of extra 
calories. Suppliers like DSM Nutritional Products, BASF Human Nutrition and FMC’s Epax division produce 
concentrates with EPA/DHA concentrations of up to 90 % (Bernasconi, 2014; 37, 38). According to Ismail 
(2013) improvements in concentration could lead to a much lower fish oil demand in the near future.  
 
2.6.3.2 Krill oil 
The high-end krill oil market has grown fastest. Krill oil is naturally high in the antioxidant astaxanthin and 
phospholipids. Marketers emphasize that EPA/DHA in krill oil have improved bioavailability as they are 
bound primarily to these phospholipids, in contrast to EPA/DHA in fish and algae oil that are primarily bound 
to triglycerides (29, 39; Ismail, 2013; Bernasconi, 2014). 
2.6.3.3 Algae oil 
Algae oil accounts for 3 % of the EPA/DHA market volume and 18 % of the value (Figure 22). Algae oil has 
some advantages over fish oil in smell/taste, oxidative stability, higher DHA vs. EPA concentrations, 
sustainability and suitability for vegetarians. Some of these disadvantages can be overcome by 
technological solutions like microencapsulation. Labelling as “vegetarian”, “kosher” and “organic” have 
                                                     
35 http://en.siriopharm.com/o-mega3/  
36 https://www.gminsights.com/industry-analysis/EPA-DHA-omega-3-ingredients-market  
37 http://www.omega3.basf.com/web/global/omega3/en_GB/index  
38 http://www.nutritionaloutlook.com/omega-3/ultra-high-concentrates-are-next-omega-3-
supplyside-west-report  
39 http://www.nutritionaloutlook.com/delivery-systems/everywhere-omega-fatty-acids  
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strengthened the demand for algae oils 40, 41, 42. EPA/DHA products from fish oil are however much lower 
in price compared these products from alternative oils. This, accompanied by a high price sensitivity in end 
consumers, has led to a slower than expected market introduction. Other challenges for algae producers 
include small market volumes per supplier, a monopolistic market nature and high costs for algae 
processing 43.  
2.6.3.4 Plant oil 
Flaxseed, canola oil, walnuts, etc. contain ALA, for which there is a big market since it is an essential 
omega-3 in human diet. Plants can produce EPA/DHA as well after insertion of algae genes. Several 
multinationals are developing genetically modified EPA/DHA rich canola oil, but for the European and 
Japanese markets only non-GMO (genetically modified organisms) products are allowed. 
2.6.4 Market regions 
North America is traditionally the largest market region for EPA/DHA (Figure 23), but the supplement market 
is becoming saturated. The Asia Pacific region, especially China, is growing fastest, while growth in the 
European market is steadier. Demand in the rest of the world (Middle East, Africa and Latin America) is 
rising as well. 
 
Figure 23 Global EPA/DHA market volume distribution44 
2.6.5 EPA/DHA market segmentation (applications) 
Most of the EPA/DHA oil is used for dietary supplements, followed by pet foods, food and beverage, infant 
formula, pharmaceuticals and clinical nutrition (Figure 24). In terms of value, the segmentation changes 
with higher shares of pharmaceuticals, infant formula and clinical nutrition (Figure 25). 
                                                     
40 http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs-
A-Global-Market-Overview.html  
41 https://www.gminsights.com/industry-analysis/EPA-DHA-omega-3-ingredients-market  
42 http://www.algaeindustrymagazine.com/the-global-algae-oil-omega-3-market-in-2014/  
43 http://www.algaeindustrymagazine.com/the-global-algae-oil-omega-3-market-in-2014/  
44 http://en.siriopharm.com/o-mega3/  
  
 
 
 
 
35 
 
Figure 24 Market segmentation global EPA/DHA market end user application by volume45  
 
Figure 25 Market segmentation global EPA/DHA market end user application by value39  
2.6.5.1 Dietary supplements  
The market for dietary supplements is still growing, with a small decrease in 2014. The North American 
market was exposed to negative media and is almost saturated. However, BRIC countries and Eastern 
Europe show an increasing demand. There is movement to krill and high concentrated fish oil, whereby the 
strong competition in the concentrates market causes price pressure (46, 47, 48; Bernasconi, 2014). 
2.6.5.2 Pet and animal feeds 
The second market (in volume) are animal feeds with added EPA/DHA, which is an average growing sector. 
The humanization of pets and demand for high quality feeds are strong drivers. Key products are puppy/ 
kitten feeds, premium food formulas and products to improve skin and coat 40, 41. 
2.6.5.3 Functional food 
There is an increasing focus on/interest in personal health and lifestyle, changing diets, functional foods 
and health benefits of omega-3. EPA/DHA fortified foods and drinks are a strong growing market. Health 
and wellness are large markets for the world’s largest food and drink companies like Nestlé. Their product 
development and marketing efforts are driving forces for market growth 40, 41. 
                                                     
45 http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs-
A-Global-Market-Overview.html  
46 https://www.packagedfacts.com/Global-EPA-DHA-7145087/  
47 https://www.gminsights.com/industry-analysis/EPA-DHA-omega-3-ingredients-market  
48 http://www.nutritionaloutlook.com/delivery-systems/everywhere-omega-fatty-acids  
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2.6.5.4 Infant formula 
Infant formula is one the fastest growing markets for omega-349. This is linked with the economic growth in 
Asia (mainly China, with an annual growth rate of almost 20 %), Eastern Europe, and, to a lesser extent, 
the Middle East and Latin America and the growing number of working women. United Nations FAO/WHO 
(Food and Agriculture Organization/World Health Organization) recommend that all infant formula should 
contain DHA and ARA and in 2011 this was the case in 87 % (Packaged Facts, 2012).   
Important players in the market like Nestlé and Abbott Laboratories developed new products 40, 41. As algae 
oils have a high DHA content they are important in this market segment. However, only DSM’s life’sDHA™ 
from algae oil is currently used in US infant formulas50.  
2.6.5.5 Pharmaceuticals  
Pharmaceuticals based on omega-3 represent a small volume, but a high value. Only Lovaza/Omacor and 
Epadel are approved yet in the US/Europe and Japan respectively and are both based on fish oil (Packaged 
Facts, 2012). The patent for Lovaza/Omacor expires within two years, so similar products will likely be 
made by other companies (D. Lochmann, personal communication, 2016). The pharmaceutical market is 
expected to grow fast due to the growing importance and application scope of cholesterol reducing 
pharmaceuticals51. Many new companies are expected to enter this market, since several drugs are in 
advanced clinical trials phases (52; Packaged Facts, 2012). 
2.6.5.6 Clinical nutrition 
The application of omega-3 in clinical nutrition has increased because of anti-inflammatory properties and 
beneficial effects for patients with trauma and chronic wounds. Clinical trials and strict regulations result in 
limited market access. Societal changes (aging populations, higher incidences of chronic diseases, 
increasing home care of patients) lead to market growth. Demand stagnates in the US and Japan, but 
increases significantly in less developed regions of Europe, Asia Pacific and Latin America (Packaged 
Facts, 2012).  
2.6.6 European market segmentation 
The European EPA/DHA market is expected to grow from about 25,000 at current to about 30,000 tonnes 
in 2020 (Figure 26) (for comparison: the global market was 124,000 tonnes in 2013). European market 
segmentation is comparable to global segmentation and every segment is likely to grow.  
                                                     
49 http://www.persistencemarketresearch.com/market-research/fatty-acids-supplements-
market.asp  
50 http://www.dsm.com/markets/foodandbeverages/en_US/products/nutritional-lipids.html  
51 https://www.gminsights.com/industry-analysis/EPA-DHA-omega-3-ingredients-market  
52 http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs-
A-Global-Market-Overview.html  
  
 
 
 
 
37 
 
Figure 26 European EPA/DHA ingredients market size by application, 2012-2022 (tonnes)46 
2.6.7 Key players EPA/DHA market 
Five companies represent about 75 % of the total EPA/DHA market. DSM leads the market, followed by 
Epax and Croda Health Care53. 
 
DSM  
DSM sells life’sDHA™, life’sOMEGA™ and MEG-3® fish oil54 
• Life’sDHA™ is an algal source of DHA as mentioned before. DSM is also developing a high-
concentrate omega-3 DHA (85 %) algae oil  
• Life’sOMEGA™ is also an algal source of EPA/DHA. It was the first vegetarian EPA/DHA product 
available as an alternative to fish sources 
• MEG-3® fish oil is an EPA/DHA omega-3 from fish oil, without fishy taste or smell  
 
Epax (part of FMC) 
Epax is part of the FMC Corporation55. Epax product lines are EPA/DHA fish oil concentrates or ultra 
concentrates (min. 700 mg/g EPA/DHA) as ethyl esters and triglycerides. Triglycerides are the natural form 
of lipids in fish. The product Epax 4535 TGN is a triglyceride oil with a minimum of 450 mg/g EPA and 350 
mg/g DHA in a total minimum of 860 mg/g.   
 
Croda Health Care 
Incromega™ products from Croda Health Care are EPA or DHA rich fish oil concentrates in various 
compositions in ethyl ester or triglyceride form56. 
 
BASF  
BASF57 is a key player in the market through its acquisition of Pronova. Pronova Pure® is sold as a 
supplement and Lovaza/Omacor (See Pharmaceuticals) as a prescription drug. They contain up to 90 % 
omega-3 fish oil content in an EPA:DHA ratio 46:38 as ethyl esters. BASF announced the acquisition of 
                                                     
53 http://www.persistencemarketresearch.com/market-research/fatty-acids-supplements-
market.asp  
54 http://www.dsm.com/markets/foodandbeverages/en_US/products/nutritional-lipids.html  
55 http://www.epax.com/  
56 http://www.crodahealthcare.com  
57 http://www.omega3.basf.com/web/global/omega3/en_GB/index  
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Equateq, a manufacturer of high-concentrate omega-3s based in Scotland. With the acquisition, BASF 
extends its portfolio of omega-3 products for the pharmaceutical and dietary supplement industries with 
concentrates with variable ratios of EPA and DHA at concentration levels of up to 99 % purity58.   
 
Cargill 
Cargill is selling IngreVita EPA/DHA Omega-3 oil. Ingrevita is a food and beverage ingredient containing 
both canola and fish oil59. 
2.6.8 PUFA share in end product cost  
Because of the proximity of the European market and because supplements are the largest and most 
transparent market segment a rough price analysis was made for online purchases of (algae or fish based) 
supplements in May 2016. Supplements offered contained 150 to 600 mg DHA/EPA and 40 mg DHA only 
(for kids). Consumer end prices ranged from € 0.15 to € 0.50 per softgel/capsule (Figure 27). 
 
Figure 27 Calculated DHA/EPA supplement consumer prices offered for online purchase per softgel/capsule, May 
2016 (green=algae products, blue=fish products) 
 
Raw materials added in the supplements with algae/fish oil (concentrates) are mostly gelling agents 
(glycerine, gelatine), starch and antioxidants. Calculated from the amount of EPA/DHA, supplements based 
on algae or fish oil are sold for about €400 – €1,500 per kg EPA/DHA and algae DHA supplements for 
about € 5,500 per kg DHA.  
2.7 Aquaculture feed market 
2.7.1 Global aquafeed market development 
Global fish production has grown steadily over the last 50 years with an average annual growth rate of 3.2 
% (FAO, 2014). Growth is mainly caused by increasing aquaculture production as capture production is 
limited (Figure 28). At current, more than half of the fish we consume is from aquaculture (FAO, 2016a).  
 
                                                     
58 http://www.nutritionaloutlook.com/delivery-systems/everywhere-omega-fatty-acids  
59 https://www.cargill.com/news/releases/2014/NA31659460.jsp  
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Figure 28 World capture fisheries and aquaculture production in million tonnes from 1950-2014 (FAO, 2016b) 
 
Aquafeed constitutes 40-50 % of aquaculture production costs 60 . Aquafeeds are compound feeds 
consisting of various raw materials and additives (e.g. corn, soy, fish meal, fish oil, wheat). As a result of 
the growing aquaculture sector and advances in feed production technologies, the aquafeed market is 
growing accordingly. The market was valued at 52,589 million € in 2013 and is projected to be 104,448 
million € by 2019 61. In volume the market was estimated to be 53,824 thousand metric tonnes in 2014 with 
a projected CAGR (Compound Annual Growth Rate) of 10.7 % from 2014-2019.  
 
Important drivers for the growing aquaculture sector are expanding populations, increasing incomes, 
changes in diet and increased seafood consumption, increasing consumer concerns and high-quality 
standards62. In addition, low-cost production technologies and alternative feed ingredients are continuously 
developed, especially in Europe56. The Asia-Pacific region has the largest aquafeed market share. Key 
players in the aquafeed market are AllerAqua A/S, Cargill, Inc., Beneo GmbH, Biomar A/S, Avanti Feeds 
Ltd, Alltech Inc., Biomin GmbH, Charoen Pokphand Foods Public Company Limited, Nutreco N.V. and 
Coppens International B.V.63.  
2.7.2 Aquatic animal type 
The largest aquafeed demand is for carp production, followed by molluscs64. Also, salmon production 
accounts for a considerable part of the aquafeed demand65. Together with demand for carp this accounted 
for 50 % of the total aquafeed consumption in 2015. In addition, aquafeed for crustaceans is expected to 
grow at the fastest rate the coming years.  
                                                     
60 http://www.thefishsite.com/fishnews/20396/fish-feed-market-forecasted-to-grow-117-
per-cent-by-2018/  
61 http://www.allaboutfeed.net/Feed-Additives/Articles/2015/11/Aquafeed-market-Global-
trends-and-forecasts-2705131W/?dossier=23678&widgetid=1  
62 http://www.prnewswire.com/news-releases/global-aquafeed-market-is-expected-to-
reach-155-billion-by-2022-575690951.html  
63 http://www.acutemarketreports.com/report/world-aquafeed-market  
64 http://www.grandviewresearch.com/industry-analysis/aquafeed-and-aquaculture-
additive-market  
65 http://www.thefishsite.com/fishnews/27439/global-aquafeed-market-expected-to-reach-
156-billion-by-2022/  
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2.7.3 Aquaculture feed ingredients 
Feeds for fish and crustaceans are similar in composition while feeds for molluscs consist for the major part 
of algae66. Soy is the most important ingredient in aquafeeds, followed by fish meal, but as a plant protein 
source, corn is expected to grow faster the coming years67. Fish meal and fish oil are important diet 
components for farmed carnivorous fish, as they supply essential amino acids and fatty acids.  
Atlantic salmon is an omnivorous fish whose feed ingredient composition in intensive farming systems is 
dependent on its life stage, but the composition is roughly shown in Figure 29. Fish meal and fish oil 
constitute a large part of the farmed salmon feed. 
 
 
Figure 29 Atlantic salmon feed ingredient composition in intensive farming systems, roughly based on Tacon et al 
(2011) 
 
To reduce aquafeed dependence on fish meal and fish oil, different alternatives are investigated and/or 
already used. Alternative ingredients include algae, insects, plants, SCP (single cell proteins) etc (Figure 
30) (Schalekamp et al, 2016). Essential fatty acid content and digestibility are important characteristics for 
these alternatives for fish oil and fish meal respectively.  
                                                     
66 http://www.prnewswire.com/news-releases/aqua-feed-market-by-end-consumption-fish-
crustaceans-mollusks-others-by-additives-antibiotics-vitamins-antioxidants-amino-acids-
feed-enzymes-feed-acidifiers-others-by-geography-global-trends--forecasts-to-2018-
209321601.html  
67 http://www.marketwatch.com/story/aquafeed-market-worth-16823-billion-usd-by-2021-
2016-04-08-92033059  
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Figure 30 Overview of alternative ingredients for fishmeal and fish oil, ranked by current level of production and its 
potential (From: Schalekamp et al, 2016) 
 
Many ingredients can partially replace fish meal with minor or no effects on fish growth, e.g. insects in the 
diets of farmed seabass68. However, fish meal prices are expected to stabilize the coming years, and this 
makes investments in alternatives more difficult69. In addition, some alternatives can lead to decreased 
growth due to lack of certain minerals/amino acids (animal by-products) or are difficult to apply due to 
logistics (fish trimmings). At the moment, insects, single cell proteins and algae are regarded as the most 
promising alternatives.  
2.7.4 Algae for aquaculture feed 
As mentioned, mollusc feeds consist for a large part of microalgae. In addition, they are used as (mostly 
live) food for larvae and juveniles of molluscs, shrimps, crustaceans and fish (freshwater and marine) and 
the culture of zooplankton for food in aquaculture. Mature fish are usually not fed on feeds containing 
microalgae, although for example Coppens recently launched Neogreen for trout, a fish meal and fish oil 
free fish feed containing omega-3 rich algae70 and Lerøy/Biomar launched a salmon feed with reduced 
marine sources and AlgaPrime DHA from Schizochytrium sp. produced by TerraVia and Bunge71. DSMs 
algae oil has been recently approved for use in aquafeed. Skretting tested the digestion of the algae oil and 
the EPA/DHA absorption with good results and they can provide feed formulations with different EPA/DHA 
ratios from algae72.      
 
Traditionally, the most commonly used species in aquaculture are Chlorella, Nannochloropsis, Tetraselmis, 
Isochrysis, Phaeodactylum, Thalassiosira, Pavlova, Chaetoceros and Skeletonema in several 
                                                     
68 http://www.feednavigator.com/Sectors/Aquaculture/European-seabass-production-
sustained-when-insects-partially-replace-fishmeal-in-diets  
69 http://www.feednavigator.com/Sectors/Aquaculture/Stable-fishmeal-prices-forecast-
alternative-protein-players-could-face-choppy-waters  
70 https://www.coppens.com/en/feed-programs/industrial/trout/466343-neogreen4663-67  
71 http://www.biomar.com/en/denmark/articles/news/wholehearted-focus-on-salmon-fed-
with-microalgae-by-leroy/  
72 http://www.feednavigator.com/R-D/Skretting-gets-behind-algal-oil-breakthrough-from-
Evonik-and-DSM?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright  
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combinations to provide a well-balanced diet. Mixed algae species lead to better growth and survival rates 
than feeds composed of only one algae species. In 1999 about 1,000 tonnes microalgae were produced 
for aquaculture (62 % for molluscs, 21 % for shrimps and 16 % for fish) (Voort, van der et al, 2015). Other 
sources (Neori, 2013) however mentioned that 240 million tonnes (!) of greenwater algae are yearly cultured 
in polyculture fish farming systems, where fish (especially carp), bivalves and shrimp feed directly on them 
or via small herbivorous protozoans and zooplankton. An equal amount of naturally occurring microalgae 
is ingested by bivalves in coastal marine farms.  
 
The PUFAFEED project focused on the production of DHA rich C. cohnii as alternative for fish oil (Sijtsma). 
Novel cultivation technologies with acetate or ethanol as carbon source enhanced DHA productivity with a 
factor 2-3. The biomass was used as feed ingredient for fish larvae after centrifugation, homogenisation 
and spray drying. Nitzschia laevis was evaluated for EPA production under heterotrophic conditions, but 
EPA production was still much lower than that of DHA. In comparison, EPA production by phototrophic 
Phaeodactylum tricornutum was not interesting due to lower lipid and EPA levels. Short term feeding trials 
with C. cohnii biomass containing feeds with salmon and sea bream did not affect growth parameters. 
Longer term experiments with salmon fed on C. cohnii and P. tricornutum led however to slightly reduced 
body weight, but no adverse effects on health. The inclusion of DHA from C. cohnii instead of fish oil would 
lead to 10 % higher production costs of salmon feed (Sijtsma, personal communication).  
 
Rabobank International expects aquafeed to become one of the first markets for algae products in which 
they will be competitive, because of decreasing marine sources and increasing prices 73 . Aquafeed 
companies, for example in the salmon sector, where 350,000 MT of fish oil is consumed yearly, are 
increasingly looking into algae and other alternative products. Technological improvements and lower 
production prices for microalgae will benefit this market.  
2.8 Livestock feed market 
2.8.1 Global livestock feed market development 
Compound feed production globally approaches an estimated 1 billion tonnes per year. Global annual 
turnover of the feed manufacturing sector is more than 337 billion € yearly. FAO estimates that by 2050 60 
% more food has to be produced with an even higher percentage increase (almost triple) in animal protein 
production74. Four of the global top 20 feed producers are located in Europe: ForFarmers, Agrifirm Group, 
De Heus and Nutreco (all in the Netherlands)75. In 2015, soy products and palm kernel expeller (imported 
into the EU) accounted for 31 % and 20% of the Dutch livestock feed respectively. Only 0.1% of Dutch feed 
is fish meal (  
                                                     
73 https://www.seafoodsource.com/news/supply-trade/algae-becoming-increasingly-
relevant-due-to-soaring-fishmeal-and-fish-oil-demand-prices  
74 www.ifif.org  
75 www.wattagnet.com 
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Table 12, based on Cormont and Van Krimpen, 2016). Fishmeal is not allowed as ruminant feed in the EU, 
but only for non-ruminants (Jedrejek et al, 2016) as a result of the spongiform encephalopathy crisis.   
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Table 12 Protein-rich feedstock volumes in Dutch livestock (poultry, pigs and cattle) feeds in 2015 (based on 
Cormont and Van Krimpen, 2016) 
Protein-rich feedstock Volume in Dutch feed  in 2015 
 
(1.000 tonnes) (%) 
Soy products 1,353 30.8 
Palm kernel expeller 879 20.0 
Sunflower expeller 745 16.9 
Rapeseed products 587 13.3 
Whey powder 361 8.2 
Corn products 225 5.1 
Vinasse 154 3.5 
Lupine 27 0.6 
Alfalfa 23 0.5 
Peas 21 0.5 
Potato protein 14 0.3 
Milk powder  6 0.1 
Fish meal 3 0.1 
Linseed 2 0.0 
Total 4,398 100.0 
 
Sustainability issues surrounding livestock feeds are important in the Netherlands, and alternatives for 
substitution of imported soy are looked into, such as locally produced algae (Spruijt et al, 2014b). Prices 
for soybean meal and fish meal have increased over the last 10 years. Price fluctuations in fish meal are 
higher than in soybean meal because of fluctuations in the supply influenced by the El Niño seasons (Figure 
31)76. 
 
Figure 31 Fish meal and soybean meal prices in euro per metric tonne 2006-201677 
                                                     
76 www.indexmundi.com  
77 www.indexmundi.com  
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2.8.2 Algae for livestock feed 
Based on dry matter content, algae contain comparable or even higher levels of protein, carbohydrates and 
lipids than conventional ingredients for livestock feeds. Nutrient composition between the different micro-
algae is variable, but most algae have a high protein content (Table 13). Research shows that algae can 
be added in diets of pigs up to a percentage of 14 % and possibly even up to 33 % without adverse effects 
on performance. In laying hens and broilers addition of 12 and 17 % algae respectively did not affect 
performance. Based on chemical composition and in vitro digestibility of dried algae the nutritional value 
was deducted, after which optimizations with these algae in pig diets were made. This showed that algae 
at a maximum cost price of € 0,30 per kg DM can compete well with other livestock feed resources. At this 
price level about 5 % dried algae are incorporated in the diet. However, the minimum cost-price for large-
scale production of algae still is still € 5 per kg DM (Spruijt et al, 2014b). 
 
Table 13 Nutrient composition of conventional feedstuffs and various algae (as % DM) (From: Lum et al, 2013) 
Feedstuff/algae Protein Carbohydrate Lipid 
Soybean 37 30 20 
Corn 10 85 4 
Wheat 14 84 2 
Anabaena cylindrica 43-56 25-30 4-7 
Arthrospira maxima (Spirulina) 60-71 13-16 6-7 
Chlorella vulgaris 51-58 12-16 14-22 
Spirogyra sp. 6-20 33-64 11-21 
Synechococcus sp. 73 15 11 
 
Different microalgae species have high lipid and PUFA contents, such as EPA and DHA (Spruijt et al, 
2014b). Feeding hens with Schizochytrium sp. resp. C. cohnii to produce ”OMEGA” eggs has proven to be 
profitable (Pulz & Gross, 2004). In addition, studies in dairy cows have focused on producing PUFA fortified 
milk, which increased PUFA concentrations in milk, with a mixed effect on the milk fat content (Lum et al, 
2013). To be able to compete with soybeans as protein source, with fish oil as PUFA source and with other 
livestock feed additives the cost price of algae must be decreased. Development of innovative, more 
productive algae cultivation systems, with limited installation and energy costs should enable this (Spruijt 
et al, 2014b). 
2.9 Regulations  
2.9.1 Regulations in the EU 
Food supplements 
Food supplements are concentrated sources of nutrients (or other substances) with a nutritional or 
physiological effect, marketed as an addition to a normal diet in “dose” form, such as pills, tablets, capsules, 
liquids in measured doses, etc. Directive 2002/46/EC contains harmonised rules to protect consumers 
against potential health risks from food supplements and misleading information 
(ec.europa.eu/food/safety/labelling_nutrition/supplements/index_en.htm). 
 
Novel foods and food ingredients 
Novel food is food not consumed to a significant degree in the European Union prior to 15 May 1997 and 
which falls under one of the categories listed in the Regulation (e.g. food consisting of or isolated from 
micro-organisms, fungi or algae). Authorisation and use of novel foods and food ingredients have been 
harmonised in the European Union by Regulation (EC) No 258/97.  Novel food will only be approved for 
use in the EU if they do not present a risk to public health, are not nutritionally disadvantageous when 
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replacing a similar food and are not misleading to the consumer. They must undergo a scientific 
assessment prior to authorisation to ensure their safety. The authorisation sets out, as appropriate, the 
conditions for their use, their designation as a food/food ingredient and labelling requirements. A novel food 
or ingredient may be marketed through a simplified procedure called "notification" (Article 5 of Regulation 
(EC) No 258/97). The company notifies the Commission about their intention to place on the market a novel 
food or ingredient based on the opinion of a Member State food assessment body that has established 
"substantial equivalence" to an already authorised novel food. Novel food is subject to the general labelling 
requirements (Regulation 1169/2011). Specific additional requirements for the labelling of novel food may 
also apply, if necessary to properly inform the consumer. The label must mention the name of the food, 
and, where appropriate, specify the conditions of use. Any nutrition and health claim should only be made 
in accordance with the Health and Nutrition Claims Regulation 1924/2006 
(ec.europa.eu/food/safety/novel_food/authorisations/index_en.htm). 
 
Feed additives 
Feed additives are products used in animal nutrition for purposes of improving the quality of feed and the 
quality of food from animal origin, or to improve the animals’ performance and health, e.g. providing 
enhanced digestibility of the feed materials. According to Regulation (EC) No 1831/2003 feed additives 
may not be put on the market unless authorisation has been given following a scientific evaluation 
demonstrating that the additive has no harmful effects, on human and animal health and on the environment 
(ec.europa.eu/food/safety/animal-feed/feed-additives/eu-rules/index_en.htm). 
 
Infant formula 
Infant formula and follow-on formula are products designed to satisfy the specific nutritional requirements 
of healthy infants (children under the age of 12 months). These products are specifically covered by 
Commission Directive 2006/141/EC. The Directive lays down the requirements for the composition and 
labelling of infant formula and follow-on formula. The annexes of the Directive give criteria for the 
composition (protein, carbohydrate, fat, mineral substances, vitamins and certain other ingredients) of 
infant formulae and follow-on formulae including, where necessary, minimum and maximum levels 
(ec.europa.eu/food/safety/labelling_nutrition/special_groups_food/children/index_en.htm).  
 
Nutrition and Health Claims on Food 
European Union rules on nutrition and health claims have been established by Regulation (EC) No 
1924/2006.  This regulation is the legal framework used by food business operators when they want to 
highlight the particular beneficial effects of their products - in relation to health and nutrition - on the product 
label or in its advertising. The rules of the Regulation apply to nutrition claims (such as "low fat", "high fibre") 
and to health claims (such as "Vitamin D is needed for the normal growth and development of bone in 
children"). The objective of those rules is to ensure that any claim made on a food’s labelling, presentation 
or advertising in the European Union is clear, accurate and based on scientific evidence. Food bearing 
claims that could mislead consumers are prohibited on the EU market. This not only protects consumers, 
but also promotes innovation and ensures fair competition. The rules ensure the free circulation of foods 
bearing claims, as any food company may use the same claims on its products anywhere in the European 
Union. A public EU Register of Nutrition and Health Claims lists all permitted nutrition claims and all 
authorised and non-authorised health claims, as a source of reference and so that full transparency for 
consumers and food business operators is ensured 
(ec.europa.eu/food/safety/labelling_nutrition/claims/index_en.htm).  
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Medicinal products 
The European system offers several routes for the authorisation of medicinal products: 
• The centralised procedure, which is compulsory for products derived from biotechnology, for 
orphan medicinal products and for medicinal products for human use which contain an active 
substance authorised in the Community after 20 May 2004 (date of entry into force of Regulation 
(EC) No 726/2004) and which are intended for the treatment of AIDS, cancer, neurodegenerative 
disorders or diabetes. The centralised procedure is also mandatory for veterinary medicinal 
products intended primarily for use as performance enhancers in order to promote growth or to 
increase yields from treated animals. Applications for the centralised procedure are made directly 
to the European Medicines Agency (EMA) and lead to the granting of a European marketing 
authorisation by the Commission which is binding in all Member States. 
• The mutual recognition procedure, which is applicable to the majority of conventional medicinal 
products, is based on the principle of recognition of an already existing national marketing 
authorisation by one or more Member States. 
• The decentralised procedure, which was introduced with the legislative review of 2004, is also 
applicable to the majority of conventional medicinal products. Through this procedure an 
application for the marketing authorisation of a medicinal product is submitted simultaneously in 
several Member States, one of them being chosen as the "Reference Member State". At the end 
of the procedure national marketing authorisations are granted in the reference and in the 
concerned Member States. 
Purely national authorisations are still available for medicinal products to be marketed in one Member State 
only. European Medicines Agency’s (EMA) main task is to co-ordinate the scientific evaluation of the safety, 
efficacy and quality of medicinal products which undergo either procedure. All scientific questions arising 
in these procedures are dealt with by the EMA (ec.europa.eu/health/authorisation-procedures_en.htm).  
2.9.2 Regulations in the US 
Dietary Supplements and dietary ingredients 
FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary 
supplements under a different set of regulations than those covering "conventional" foods and drug 
products. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA): 
• Manufacturers and distributors of dietary supplements and dietary ingredients are prohibited from 
marketing products that are adulterated or misbranded.  That means that these firms are 
responsible for evaluating the safety and labelling of their products before marketing to ensure 
that they meet all the requirements of DSHEA and FDA regulations. 
• FDA is responsible for taking action against any adulterated or misbranded dietary supplement 
product after it reaches the market. 
Unlike drugs, supplements are not intended to treat, diagnose, prevent, or cure diseases. That means 
supplements should not make claims, such as “reduces pain” or “treats heart disease.” Claims like these 
can only legitimately be made for drugs, not dietary supplements. Under existing law, including the Dietary 
Supplement Health and Education Act passed by Congress in 1994, the FDA can take action to remove 
products from the market, but the agency must first establish that such products are adulterated (e.g., that 
the product is unsafe) or misbranded (e.g., that the labelling is false or misleading) 
(www.fda.gov/Food/DietarySupplements/).  
 
Pet food 
There is no requirement that pet food products have pre-market approval by the FDA. However, FDA 
ensures that the ingredients used in pet food are safe and have an appropriate function in the pet food. 
Many ingredients such as meat, poultry and grains are considered safe and do not require pre-market 
approval. Other substances such as sources of minerals, vitamins or other nutrients, flavourings, 
preservatives, or processing aids may be generally recognized as safe (GRAS) for an intended use (21 
CFR 582 and 584) or must have approval as food additives (21 CFR 570, 571 and 573) 
(www.fda.gov/AnimalVeterinary/Products/AnimalFoodFeeds/PetFood/default.htm). 
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Food additives 
Any substance that is reasonably expected to become a component of food is a food additive that is subject 
to premarket approval by FDA, unless the substance is generally recognized as safe (GRAS) among 
experts qualified by scientific training and experience to evaluate its safety under the conditions of its 
intended use, or meets one of the other exclusions from the food additive definition in section 201(s) of the 
Federal Food, Drug, and Cosmetic Act (FFDCA). Any food additive that is intended to have a technical 
effect in the food is deemed unsafe unless it either conforms to the terms of a regulation prescribing its use 
or to an exemption for investigational use. Otherwise, in accordance with section 409 of the Act, the 
substance is deemed an unsafe food additive. Any food that contains an unsafe food additive is adulterated 
under section 402(a)(2)(C) of the FFDCA 
(www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ucm228269.htm). 
 
Infant formulas 
Because infant formula is a food, the laws and regulations governing foods apply to infant formula. 
Additional statutory and regulatory requirements apply to infant formula, which is often used as the sole 
source of nutrition by a vulnerable population during a critical period of growth and development. These 
additional requirements are found in section 412 of the FFDCA and FDA's implementing regulations in 21 
CFR 106 and 107.  FDA does not approve infant formulas before they can be marketed. However, all 
formulas marketed in the United States must meet federal nutrient requirements and infant formula 
manufacturers must notify the FDA prior to marketing a new formula. If an infant formula manufacturer does 
not provide the elements and assurances required in the notification for a new or reformulated infant 
formula, the formula is defined as adulterated under section 412(a)(1) of the FFDCA and FDA has the 
authority to take compliance action if the new infant formula is marketed. FDA has requirements for 
nutrients in infant formulas, which are located in section 412(i) of the FFDCA and 21 CFR 107.100 
(www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/infantformula/ucm05652
4.htm#q2).  
 
Nutrient Content Claims 
The Nutrition Labelling and Education Act of 1990 (NLEA) permits the use of label claims that characterize 
the level of a nutrient in a food (i.e., nutrient content claims) if they have been authorized by FDA and are 
made in accordance with FDA's authorizing regulations. Nutrient content claims describe the level of a 
nutrient in the product, using terms such as free, high, and low, or they compare the level of a nutrient in a 
food to that of another food, using terms such as more, reduced, and light.  A summary of the rules for use 
of nutrient content claims can be found in Chapter VI of The Food Labelling Guide. Examples of nutrient 
content claims can be found in Appendices A and B 
(www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm111447.htm). 
 
Health Claims on Food 
Health claims describe a relationship between a food substance (a food, food component, or dietary 
supplement ingredient), and reduced risk of a disease or health-related condition.  Appendix C of The Food 
Labelling Guide contains a summary of those health claims that have been approved for use on food and 
dietary supplement labels 
(www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm111447.htm). 
GOED is still waiting to hear back from FDA on whether or not DHA/EPA will be granted a qualified health 
claim for reduction of blood pressure. Although FDA has postponed its decision three times and could 
postpone again, it would be surprising if the agency does not come back with a final decision in 2016. 
GOED also continues to hope that EPA/DHA will be selected to undergo an Institute of Medicine (IOM) 
Dietary Reference Intake (DRI) review (www.nutritionaloutlook.com). 
 
Drug registration 
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The Federal Food, Drug, and Cosmetic Act requires firms that manufacture, prepare, propagate, 
compound, or process drugs in the U.S. or that are offered for import into the U.S. to register with the FDA. 
These domestic and foreign firms must at the time of registration, list all drugs manufactured, prepared, 
propagated, compounded, or processed for commercial distribution in the U.S.  Additionally, foreign 
establishments must identify a U.S. agent and importers at the time of their registration. Registration 
information must be renewed annually 
(www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/DrugRegistrationandListing/default.htm) 
 
Regulation and control of new drugs in the United States has been based on the New Drug Application 
(NDA). The goals of the NDA are to provide enough information to permit FDA reviewer to reach the 
following key decisions: 
• Whether the drug is safe and effective in its proposed use(s), and whether the benefits of the 
drug outweigh the risks. 
• Whether the drugs proposed labelling (package insert) is appropriate, and what it should contain. 
• Whether the methods used in manufacturing the drug and the controls used to maintain the 
drug's quality are adequate to preserve the drug's identity, strength, quality, and purity. 
 The documentation required in an NDA is supposed to tell the drug's whole story, including what happened 
during the clinical tests, what the ingredients of the drug are, the results of the animal studies, how the drug 
behaves in the body, and how it is manufactured, processed and packaged 
(www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalAppli
cations/NewDrugApplicationNDA/default.htm). 
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3 Life Cycle Costing (LCC) of Algae-based PUFA production 
By Marcel van der Voort 
3.1 Goals and scope 
The PUFAChain project is aiming to develop and contribute to sustainable PUFA production based on 
phototrophic algae. The economic analysis consists out of a macro- (Chapter 2) and micro- (this Chapter) 
economic part. This micro-economic analysis, combined with the macro-economic analysis, should provide 
insight in the economic viability of a future mature production chain for PUFAs from phototrophic algae. 
The main goal is to provide insight into the economic sustainability, but there are a few secondary goals:  
• Insight in the economic sustainability per scenario 
• Insight in the effect of each production chain step on the overall cost price 
• Recommendations towards a mature production chain in 2025 
The results can be used by project partners of the PUFAChain project to research and implement 
(technological) improvements or market strategies. 
 
Unlike the LCA part of the sustainability assessment (Keller et al, 2017a), the LCC part will not perform 
calculations on the competing supply chains (reference systems). Instead the market price of the competing 
products (reference products) will be used as guideline. The macro-economic analysis (Chapter 2) will 
provide the market price reference. 
3.2 System boundaries 
Task 9.1 describes the definitions, settings and system descriptions. More information can be found in the 
report on the definitions, settings and system descriptions. The Deliverable 9.1 and 9.3 reported in Keller 
et al, 2017a. 
3.3 Methodology 
For this micro-economic assessment, the Life Cycle Sustainability Assessment (LCSA) methodology of 
UNEP/SETAC is used as reference for the approach and methodology. The life cycle assessment (LCA) 
and life cycle costing (LCC) are related and share the same goals, definitions and settings. The partners 
within work package 9 (WP9) of the PUFAChain project organized a number of definition & settings 
meetings during the course of the project. The sustainability assessment in PUFAChain project is aiming 
for a mature industrial scale production plant by 2025. This plant will produce PUFAs from phototrophic 
algae: DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid) and SDA (stearidonic acid). The WP9 
meetings with partners lead to a set of seven scenarios.  
Two main regions will be assessed in six scenarios (Table 14): Southern Europe (region around Lisbon) 
and Central Europe (region around Munich). In addition, one scenario for Northern Europe (region around 
Oslo) was added. Either a Conservative performance of 10-hectare (net) area or an Optimistic performance 
of 100 hectare (net) area is taken into account per regional scenario as size reference. All scenarios are 
for 2025. The following strains of algae were used for the calculations: Prorocentrum cassubicum (SAG 
40.80), Thalassiosira weissflogii (CCAP 1085/18) and a combination of Chloridella simplex (SAG 51.91) 
and Raphidonema nivale Lagerheim (CCCryo 381-11). The potential algae strains were evaluated during 
the course of the project.  
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Table 14 Overview of seven scenarios investigated 
Location Algae Season (days) per strain Main products 
Lisbon Prorocentrum1) All year (330 days) EPA, DHA & SDA 
Lisbon Thalassiosira1) All year (330 days) EPA, DHA  
Lisbon Chloridella2)/Raphidonema2) Summer (240), winter (90) EPA 
Munich Prorocentrum All year (330 days) EPA, DHA & SDA 
Munich Thalassiosira All year (330 days) EPA, DHA  
Munich Chloridella/Raphidonema Summer (120), winter (210) EPA 
Oslo (100 ha) Chloridella/Raphidonema Summer (80), winter (250) EPA 
1) Seawater strain 2) Freshwater strain 
 
The LCC is mainly assessing the influence of geography/climate, scale and algae strain on the costs of a 
potential mature production plant. This analysis leads to more insight whether a potential PUFA supply 
chain based on phototrophic algae can economically compete with other sources of EPA/DHA.  
 
Within WP9 one common dataset was compiled. The WP9 dataset contains input of all the project partners, 
especially A4F, Mahle Innowa, NATEX, IOI Cremer and Fraunhofer IZI-BB. This data was either already 
available at the partners or based on research, pilot and demo tests during the course of the PUFAChain 
project. The data combined with commercial experience and knowledge of partners are used to make 
expert judgements on the potential supply chain for 2025, mainly for the 100 ha (Optimistic) scenario. The 
capital expenditure data were fine-tuned with the Business Case study in WP5 of the PUFA Chain project. 
The data used in the micro-economic assessment is based on the dataset of July 2017. The Oslo scenario 
was not part of the WP5 Business Case study. Therefore, the CAPEX values for Oslo are calculated 
separately and based on extrapolation and expert judgement of the data for Lisbon and Munich. 
 
The micro-economic analysis follows the LCC approach, which assesses the costs within a supply chain 
related to the life cycle of the product (Swarr et al., 2011). The costs are modelled in a linear way. The 
capital and operational costs of all separate supply chain steps for producing EPA/DHA from different algae 
strains are taken into account. This results in a cost price per kg EPA/DHA (functional unit). The cost prices 
or costs used represent the actual market prices needed. Therefore, the final cost prices reflect the total 
(gross) value added throughout the supply chain (Hunkeler et al., 2008). 
 
To create a common basis for all scenarios the following assumptions/starting points were decided on: All 
equipment needed, including the land, are purchased. No interest costs of the capital expenditures are 
included, except for the land needed. There is no life expectancy (no depreciation period) implemented on 
the land purchased for the production and processing site(s). This in accordance with IFRS guidelines 
(www.ifrs.org). Other capital expenditures have a linear depreciation for their life expectancies. All capital 
expenditures are depreciated to nil due to the large uncertainties and tailor-made solutions implemented.  
The operational expenses are based on the values, e.g. for electricity, of the WP9 dataset and current 
market prices. Disposal costs of waste and waste water are included. For all relevant scenarios the required 
saltwater is produced by adding salt to freshwater. Therefore, no purified seawater is applied for the salt 
water algae strains. 
 
Although the LCC is modelling an industrial scale production for 2025, current cost prices are used. 
Therefore, future increases in labour and other costs per region or scenario have not been taken into 
account. The same is applied on all operational expenditures. 
 
As mentioned above a great deal of uncertainty is connected to the modelling of an industrial scale 
production for PUFAs based on phototrophic algae. New developments in for example technology, biology, 
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economy, environment and social perceptions could influence the outcome significantly. The modelling is 
done with the research questions as starting point. This micro-economic assessment should not be 
interpreted as an actual business case. 
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3.4 Descriptions for the life cycle costing of PUFAChain 
This paragraph highlights the most significant settings used for the LCC per process step.  
3.4.1 Algae strains, crop rotation and cultivation process 
The PUFAChain focuses on the phototrophic cultivation of microalgae in fresh or saltwater media. The 
algae cultivation system was assessed during the course of the PUFAChain project in WP3 and WP4. The 
cultivation system selected is an Unilayer Horizontal Tubular Photo BioReactor (UHT-PBR).  
The algae cultivation process consists of the following steps: 
- Culture medium preparation 
- Inoculation of small flasks (with LED lighting) 
- Green wall panels (several litres to m3) 
- Production in UHT-PBRs 
- Semi-continuous cultivation with periodic partial harvests 
 
For the Chloridella/Raphidonema option a rotation in algae strains between seasons is included based on 
their temperature optima. CAPEX values per installation and scenario are based on the WP5 data of partner 
A4F, dataset of July 2017. All CAPEX values are calculated per year, based on the life-expectancy. The 
OPEX and production values were also calculated per year. 
The production and processing installations and equipment consists out of the following items. 
- Offices, warehouse and workshop 
- Laboratories 
- Control and electrical systems 
- Civil engineering 
- Licencing, EPC and contractor costs 
- Water treatment systems 
- Nutritive medium preparation systems 
- Production systems 
- Thermo-regulation system 
- Effluents and medium recycling 
 
Land area needed for the production facilities is included in the calculations. The hectares mentioned in 
each scenario are net (photosynthetic) area. Per scenario the area needed is increased by 35 % to achieve 
a viable estimate of total production area needed. Additional/auxiliary processes at the production location, 
harvesting, drying and cell disruption also require space. Of the 35 % additional space 20 % is expected at 
the algae production site and 15 % for the extraction and oil processing site. The land prices used are 
based on current real estate prices for industrial area. The current price levels of real estate are taken. This 
approach simulates a project were an investor purchases industrial area for realizing PUFA production 
based on algae. Due to rising real-estate prices, this approach negatively influences the outcome. Other 
options could benefit the scenarios significantly, mainly due to the high share in CAPEX of land costs (see 
Table 15). These options could be brownfield sites, and/or an investor already has land available. 
3.4.2 Calculated algae cultivation values 
The production is the most significant supply chain step in costs. The calculated results specific for the 
algae production are stated below. The calculated values for the CAPEX are stated, including the share of 
the two most significant cost elements. For the OPEX the calculated values are stated, including the share 
of all cost elements. 
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Table 15 Calculated CAPEX values for infrastructure/installations (in EUR/year) used per scenario including the 
share of the two main cost items (EUR/year) 
 Southern Central Northern 
Value/Scenario 10 ha 100 ha 10 ha 100 ha 100 ha 
CAPEX (EUR/year) 2,646,287 24,590,861 3,146,253 29,506,076 41,356,705 
UHT-PHR installation (%) 17% 15% 15% 13% 10% 
Land (%) 71% 76% 74% 79% 84% 
 
The calculated OPEX costs are discussed in the following three paragraphs. This to highlight geographical 
differences. 
3.4.2.1 Calculated OPEX values of algae cultivation for Southern Europe 
The intermediate results for the OPEX give an insight in the most significant cost elements for PUFA 
production for Southern Europe. All Southern Europe scenarios give the same costs elements that 
contribute the most in the OPEX. These are labour, water, electricity and CO2. 
 
Table 16 Production values Prorocentrum cassubicum, Thalassiosira weissflogii and the ACR option (Chloridella 
simplex and Raphidonema nivale Lagerheim) for Southern Europe (Conservative and Optimistic performance) per 
year 
Value for: Prorocentrum cassubicum Thalassiosira weissflogii Chloridella/ Raphidonema 
Scenario 10 ha 100 ha 10 ha 100 ha 10 ha 100 ha 
OPEX 2,830,200 35,227,500 2,302,000 25,866,600 2,456,700 31,523,100 
Nutrients 3% 2% 3% 3% 1% 1% 
CO2 8% 7% 9% 9% 1% 1% 
Water 23% 19% 29% 26% 26% 20% 
Silicates 1% 0% 1% 1% 0% 0% 
Salt 2% 2% 3% 3% 0% 0% 
Electricity 9% 7% 15% 13% 10% 9% 
Waste 1% 1% 2% 2% 2% 1% 
O&M costs 4% 3% 5% 5% 5% 4% 
Labour costs 49% 58% 33% 39% 57% 65% 
 
3.4.2.2 Calculated OPEX values of algae cultivation for Central Europe 
The intermediate results for the OPEX give an insight in the most significant cost elements for PUFA 
production for Central Europe. All Central Europe scenarios give the same costs elements that contribute 
the most in the OPEX. These are labour, water, electricity and CO2. The production parameters for 
Prorocentrum cassubicum and Thalassiosira weissflogii were nearly identical. As a result, the calculated 
results are also identical for both algae strains. 
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Table 17 Production values Prorocentrum cassubicum, Thalassiosira weissflogii and the ACR option (Chloridella 
simplex and Raphidonema nivale Lagerheim) for Central Europe (Conservative and Optimistic performance) 
Value for: Prorocentrum cassubicum Thalassiosira weissflogii Chloridella/ Raphidonema 
Scenario 10 ha 100 ha 10 ha 100 ha 10 ha 100 ha 
OPEX 2,009,950 27,332,700 2,009,950 27,332,700 1,714,950 24,198,450 
Nutrients 3% 2% 3% 2% 3% 3% 
CO2 7% 6% 7% 6% 4% 3% 
Water 2% 2% 2% 2% 3% 3% 
Silicates 1% 0% 1% 0% 0% 0% 
Salt 2% 2% 2% 2% 0% 0% 
Electricity 18% 13% 18% 13% 15% 10% 
Waste 6% 5% 6% 5% 2% 2% 
O&M costs 6% 5% 6% 5% 7% 6% 
Labour costs 56% 65% 56% 65% 65% 74% 
 
3.4.2.3 Calculated OPEX values of algae cultivation for Northern Europe 
The intermediate results for the OPEX give an insight in the most significant cost elements for PUFA 
production using the Optimistic ACR scenario for Northern Europe. The ACR option for Chloridella/ 
Raphidonema shows differences per scenario. The Southern Europe scenario shows a high water need 
compared to Central and Northern Europe. The Northern Europe scenario shows the lowest inputs except 
for the labour needed. The labour costs are more or less fixed. The inputs needed such as water, electricity 
and CO2 are related to the algae biomass produced. The amounts of algae biomass produced change per 
scenario for all strains. For Chloridella/Raphidonema the difference between the Optimistic performance 
scenarios for Southern Europe (about 2,900 kg yield) and Central Europe (about 2,100 kg yield) were small 
compared to the other two strains. The Northern Europe scenario produced about 1,600 kg of algae 
biomass. Since inputs are strongly related to yields, this indicates the differences between the European 
regions. 
 
Table 18 Production values for the ACR option (Chloridella simplex and Raphidonema nivale Lagerheim) for 
Northern Europe (Optimistic performance) 
Value for: Chloridella/ Raphidonema 
Scenario 100 ha 
OPEX 26,489,369 
Nutrients 1% 
CO2 2% 
Water 1% 
Silicates 0% 
Salt 0% 
Electricity 7% 
Waste 5% 
O&M costs 7% 
Labour costs 77% 
 
3.4.3 Settings and descriptions further PUFA supply chain steps 
The supply chain steps from production to oil processing are taken into account for this micro-economic 
assessment. After production the steps of harvesting, cell disruption, drying, extraction and oil processing 
are incorporated. Below the most significant settings and process descriptions are stated.  
3.4.3.1 Algae harvesting, cell disruption and drying settings and description 
The algae harvesting is done by membrane concentration including filtration. The osmotic shock method 
for cell disruption of the algae strains Prorocentrum and Thalassiosira is applied. The cell disruption method 
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for Chloridella and Raphidonema is bead milling. Data on bead milling was not available within the 
PUFAChain project and were taken from the EnAlgae project (Kenny et al., 2015, derived from 
Balasundaram et al., 2012). There is no differentiation per algae strain in installation size. 
 
All filtration, diafiltration and drying equipment is assumed to have a depreciation period of 10 years. The 
harvesting of the microalgae by membrane filtration (Mahle Innowa) has been tested in practice in WP 4 in 
a pilot scale set-up. The data on concentration and diafiltration are made available by project partners A4F 
and Mahle Innowa. All strains need cell disruption as mentioned above. The algae paste is dried by spray-
drying in all scenarios. During data collection and initial calculations, the disruption efficiency proved to be 
a significant factor. Supercritical CO2-extraction was able to extract nearly all algae oil from the biomass. 
The previous step of cell disruption determines the efficiency of successive steps. The yield in EPA/DHA is 
therefore influenced significantly by the efficiency of cell disruption and also by losses during drying and 
harvesting. The biomass produced is a starting point for the further supply chain steps. The biomass yield 
influences for example the energy demand for further processing. The difference in algae biomass yield 
per scenario/geographical location is therefore a significant factor for inputs needed further down in the 
supply chain. 
3.4.4 Algae Biomass processing 
Processing of the algae biomass is done in a two-step process. The first step is supercritical CO2-extraction, 
followed by processing of the extracted oil to obtain the PUFAs. The production, harvesting, cell disruption 
and drying are all assumed to be at the production location of the algae. In the scenarios the geographical 
locations Southern Europe (Lisbon area), Central Europe (Munich area) and Northern Europe (Oslo area) 
were used as reference. Supercritical CO2-extraction and further processing of the oil are assumed to take 
place at a central location in Germany for all locations/scenarios. As such, transportation is needed from 
the production location to the extraction and processing location. 
 
As mentioned above cell disruption degree determines to a significant extent the efficiency of the 
supercritical CO2-extraction. The same is true for losses during purification, since these parameters directly 
influence the yield in kilogram EPA/DHA/SDA (Functional Unit).  
 
The data on extraction an oil processing is collected within WP9 and provided by project partners NATEX 
and IOI Oleochemical. The processes include extraction of oil from the algae biomass, PUFA concentration 
and separation and downstream processing. The IOI Oleochemical location In Central Germany is taken 
as reference for example for the land costs. The amount of land needed for processing is estimated at 20% 
of the net area of production per scenario. The location is the same for all scenarios, including the prices 
of land and installations. There is difference in CAPEX per scenario for extraction and oil processing. This 
difference is based on the expected produced amounts of algae biomass. The CAPEX is a static number 
in the modelling. The changes in volumes produced do not change the size of the installation. 
 
Supercritical CO2-extraction of algae biomass results in two main products: Algae oil containing the desired 
PUFAs and a dry powder high in polysaccharides. The by-products also contain protein. Potential uses of 
the by-product(s) have not been evaluated in WP9.4. An option is to use the by-products as feedstock for 
anaerobic digestion. Although it is expected that the by-product could be used higher up in the value 
pyramid, e.g. for food or feed (Chapter 2) in the near future. 
3.4.4.1 Prices and price quotations 
The CAPEX and OPEX costs are determined as specific as possible for each scenario/geographical 
location. Price quotations for the industrial area are taken from listings of real estate agents. Hourly wages 
for labour are primarily based on statistical data combined with labour market reports per geographical 
location. All other operational costs are provided by price quotations of potential suppliers. 
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3.4.5 Calculated costs of the total supply chain 
The calculations give an indication on the economic viability of a potential supply chain of PUFAs based on 
phototrophic algae. The figures included below state the relation between the supply chain steps. The 
CAPEX and OPEX are separated for clarity per supply chain step. The production is for all strains, 
Conservative or Optimistic performance and region the most significant element in costs. The CAPEX and 
OPEX are stated below for the whole supply chain. The next paragraph will the results per Functional Unit.  
 
The calculated results of the Southern Europe Optimistic scenarios are taken as example. This to visualise 
the share of each of the supply chain step within the total costs. The proportions of other 
scenarios/geographical locations are not identical, but do show much similarity. Therefore, only the 
Southern Europe Optimistic scenarios are taken as example. The results for all scenarios per Functional 
Unit are stated in the next Chapter 3.5. 
 
These results signal a few important aspects in consideration of realising a PUFA supply chain of 
phototrophic algae. The CAPEX and OPEX of production of algae are strongly influencing the 
competitiveness of the overall supply chain. The figures below provide insight for business partners to focus 
improvements on relevant supply chain steps. 
 
The figures show that the CAPEX is mainly determined by the cultivation/production CAPEX. The OPEX is 
mainly production, but also the costs for drying are a significant cost element in the OPEX. The 
concentration/filtration and cell disruption combined are for Chloridella and Raphidonema a significant cost 
element in OPEX. The additional need for bead milling adds to the cost for this supply chain step. Another 
capital-intensive supply chain step is the Oil Processing. The CAPEX is, as mentioned, fixed to the size 
determined per scenario. The difference per strain are therefore limited. 
 
 
Figure 32 CAPEX for each of the three strains of the Optimistic performance scenario for Southern Europe 
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The OPEX varies per strain. In the Optimistic performance for Southern Europe the Thalassiosira strain 
has the lowest inputs and therefore costs.  The Prorocentrum strain has higher OPEX cost, but a 
significantly higher yield. The next paragraph will state results based on the Functional Unit of kilogram 
EPA/DHA.  
 
Figure 33 OPEX for each of the three strains of the Optimistic performance scenario for Southern Europe 
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3.5 Life Cycle Costs Assessment 
3.5.1 General remarks 
The CAPEX is based on a fixed set of installations per area size/scenario. The same approach was used 
for a number of OPEX cost units, such as Operation and Maintenance costs and labour. An actual supply 
chain in 2025 would probably be designed more specific for each type of algae strain used. As such the 
modelling is a prediction based on current knowledge, experience and data. A secondary goal of the LCC 
modelling was to inform the partners within the PUFAChain project on the most relevant costs and their 
influence on the overall PUFA supply chain performance. 
 
The costs of land are incorporated in the model. The current real-estate prices of industrial area for Lisbon, 
Munich and Oslo were used. The reason for this remark is that all regions are (the most) expensive regions 
per country concerned. The costs for industrial land are therefore high compared to other regions within 
the same country. The location in alternative areas/locations in the vicinity of these cities could provide 
better options for an economically viable PUFA supply chain in 2025.  
3.5.2 Results of the Life Cycle Costing 
The algae supply chain is calculated from production of resources to end product (algae production and 
processing, algae harvesting, cell disruption and drying and algae biomass processing by supercritical CO2-
extraction and oil processing). This results in a cost price per kg EPA/DHA (functional unit) for each 
production scenario. As reference the market values of competing products (‘reference products’) are 
taken. The global market volume for omega-3 PUFA was around 115,000 MT in 2012 (Industry Experts, 
2014). Market segments are dietary supplements, pet food, food & beverages, infant nutrition, 
pharmaceuticals and clinical nutrition (Table 2). Price ranges for dietary supplements based on algae or 
fish oil are around €400 – €1,500 per kg EPA/DHA and up to € 5,500 per kg for pure DHA (Industry Experts, 
2014) (Chapter 2.6.8). This price range represents an end-user price. The actual business to business price 
range is expected to be lower.  
3.5.2.1 Overall results of scenarios 
A number of scenarios fall within the stated price range of €400 – €1,500 per kg EPA/DHA. Only four 
scenarios fall outside this range. A number of potential improvements are discussed in Chapter 3.7.   
Table 19 Cost price EPA/DHA/SDA (€/kg) per scenario 
Scenario Conservative Optimistic  
 (10 ha) (100 ha) 
South (Prorocentrum) 848 704 
South (Thalassiosira) 1359 468 
South (Chloridella + Raphidonema) 1156 932 
Central (Prorocentrum) 1196 997 
Central (Thalassiosira) 2058 753 
Central (Chloridella + Raphidonema) 2344 1915 
North (Chloridella + Raphidonema)  3903 
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Figure 34 Overall results in cost price EPA/DHA/SDA (€/kg) per region, algae strain for the Conservative and Optimistic 
performance scenarios (including market price range) 
3.5.2.2 Results for Southern Europe 
All costs were calculated per Functional Unit (FU) per year. The FU in this case is the amount of 
EPA/DHA/SDA produced in kilogram. All calculations combined give an overall result for the whole supply 
chain per algae strain, scenario and location. In addition to the overall results, the share of each step in the 
supply chain in the overall costs is given. 
 
The Prorocentrum cassubicum strain is a supplier of EPA, DHA and SDA. This saltwater algae is produced 
all year (330 days). The Prorocentrum cassubicum is an interesting algae strain, especially in the 
Conservative scenario for Southern Europe. The lower performance of Prorocentrum cassubicum for the 
Optimistic performance scenarios for Southern Europe is due to the lower oil content compared to 
Thalassiosira weissflogii. This combined with the scale of production results in significant differences. 
The Prorocentrum cassubicum strain has the best results of this study for the Conservative performance 
scenario for Southern Europe. 
 
Table 20 LCC outcome for production of Prorocentrum in Southern Europe (Conservative and Optimistic 
performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha 100 ha 
Cost price EPA/DHA/SDA (€/kg) 848 704 
Total costs of supply chain (€/year) 8,237,089 83,449,152 
Total CAPEX (€/year)  3,278,520 29,917,094 
Total OPEX (€/year) 4,958,569 53,532,058 
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Figure 35 Cost components of PUFA production from Prorocentrum cassubicum in Southern Europe (Conservative 
and Optimistic performance scenario) 
 
The Thalassiosira weissflogii strain is a supplier of EPA and DHA. This saltwater algae is produced all year 
(330 days). As mentioned above Thalassiosira weissflogii performs well in the Optimistic performance 
scenario for Southern Europe. The scale of production and higher oil content favour the Thalassiosira strain. 
The lower inputs and thus lower OPEX needed complement the results of Thalassiosira further. 
The Thalassiosira strain in the Optimistic performance scenario for Southern Europe has the best results 
of this study. Even so the Thalassiosira in the Conservative performance scenario (10 ha) fall also within 
the market price range. Although it is on the high end of the price range. 
 
Table 21 LCC outcome for production of Thalassiosira in Southern Europe (Conservative and Optimistic performance 
scenario) 
 Values for Thalassiosira weissflogii 
Scenario 10 ha 100 ha 
Cost price EPA/DHA (€/kg) 1,359 468 
Total costs of supply chain (€/year) 7,454,621 71,327,122 
Total CAPEX (€/year)  3,278,520 29,917,094 
Total OPEX (€/year) 4,176,101 41,410,028 
   
 
 
  
 
 
 
 
62 
 
Figure 36 Cost components of PUFA production from Thalassiosira weissflogii in Southern Europe (Conservative 
and Optimistic performance scenario) 
 
The Chloridella/Raphidonema strains are suppliers of EPA. These are freshwater algae and are produced as 
ACR option. For Southern Europe Chloridella is produced during summer (240 days) and Raphidonema 
during winter (90 days). The ACR option was research to assess for example effects of cultivation of strains 
during suitable conditions regarding light, temperature, etc. The Chloridella/ Raphidonema strains fall within 
the market price range reference. Although the Chloridella/Raphidonema strains are out-performed by the 
Prorocentrum and Thalassiosira strains for Southern Europe in both performance scenarios. 
 
Table 22 LCC outcome for production of Chloridella/Raphidonema in Southern Europe (Conservative and Optimistic 
performance scenario) 
 Values for Chloridella/Raphidonema 
Scenario 10 ha 100 ha 
Cost price EPA (€/kg) 1,156 932 
Total costs of supply chain (€/year) 8,212,784 81,887,957 
Total CAPEX (€/year)  3,495,880 32,299,694 
Total OPEX (€/year) 4,716,904 49,588,264 
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Figure 37 Cost components of PUFA production from Chloridella/Raphidonema in Southern Europe (Conservative 
and Optimistic performance scenario) 
3.5.2.3  Results for Central Europe 
All costs were calculated per Functional Unit (FU) per year. The FU in this case is the amount of EPA/DHA 
produced in kilogram. All calculations combined give an overall result for the whole supply chain per algae 
strain, scenario and location. The results for Central Europe are calculated in a similar way with scenario 
specific data for the region and production. All data combined result in costs for the whole supply chain per 
algae strain, scenario and location. The share of each step in the overall supply chain costs is also shown. 
 
Due to higher costs and lower production all performance scenarios and strain for Central Europe perform 
less than the Southern Europe scenarios. Although a number of Central Europe scenarios do perform within 
the market price range used. The both performance scenarios for Prorocentrum for Central Europe are 
within the market price range. This is also the case for Thalassiosira in the Optimistic Performance scenario 
for Central Europe. 
 
Table 23 LCC outcome for production of Prorocentrum in Central Europe (Conservative and Optimistic performance 
scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha 100 ha 
Cost price EPA/DHA/SDA (€/kg) 1,196 997 
Total costs of the supply chain (€/year) 7,747,592 78,797,255 
Total CAPEX (€/year)  3,637,655 33,256,119 
Total OPEX (€/year) 4,109,936 45,541,136 
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Figure 38 Cost components of PUFA production from Prorocentrum cassubicum in Central Europe (Conservative 
and Optimistic performance scenario) 
 
The Thalassiosira weissflogii strain is a supplier of EPA and DHA. This saltwater algae is produced all year 
(330 days). As mentioned above the Thalassiosira in the Optimistic Performance scenario for Central 
Europe falls within the market price range. 
 
Table 24 LCC outcome for production of Thalassiosira in Central Europe (Conservative and Optimistic performance 
scenario) 
 Values for Thalassiosira weissflogii 
Scenario 10 ha 100 ha 
Cost price EPA/DHA (€/kg) 2,058 753 
Total costs of the supply chain (€/year) 7,523,964 76,549,562 
Total CAPEX (€/year)  3,637,655 33,256,119 
Total OPEX (€/year) 3,886,308 43,293,443 
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Figure 39 Cost components of PUFA production from Thalassiosira weissflogii in Central Europe (Conservative and 
Optimistic performance scenario) 
 
The Chloridella/Raphidonema strains are suppliers of EPA. These are freshwater algae and are produced as 
ACR option. For Central Europe Chloridella is produced during summer (140 days) and Raphidonema 
during winter (190 days). This is based on the temperature and light intensity for Central Europe in regard 
to the strains cultivated. 
The Chloridella/Raphidonema strains fall outside the market price range reference. The 
Chloridella/Raphidonema strains are for Central Europe out-performed by the Prorocentrum and 
Thalassiosira strains in both performance scenarios. This is mainly due to a lower biomass yield. 
 
Table 25 LCC outcome for production of Chloridella/Raphidonema in Central Europe (Conservative and Optimistic 
performance scenario) 
 Values for Chloridella/Raphidonema 
Scenario 10 ha 100 ha 
Cost price EPA (€/kg) 2,344 1,915 
Total costs of the supply chain (€/year) 7,651,590 77,246,371 
Total CAPEX (€/year)  3,804,855 34,986,639 
Total OPEX (€/year) 3,846,734 42,259,732 
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Figure 40 Cost components of PUFA production from Chloridella/Raphidonema in Central Europe (Conservative and 
Optimistic performance scenario) 
3.5.2.4 Results for Northern Europe 
The scenario for the Northern Europe (Oslo region) was only calculated for Chloridella/Raphidonema in the 
Optimistic performance scenario (100 hectare). The results for Oslo region are calculated in a similar way 
with scenario specific data for the region and production. All calculations combined result in costs for the 
whole supply chain. The share of each step in the overall supply chain costs is also shown. 
 
The Northern Europe scenario was added to the Southern and Central Europe scenarios. As mentioned in 
the settings the Chloridella/Raphidonema strain could perform well in colder temperature and lower light 
intensity conditions. The Chloridella/Raphidonema strains are suppliers of EPA. These are freshwater 
algae and they are produced as ACR option. For Northern Europe Chloridella is produced during summer 
(80 days) and Raphidonema during winter (250 days). This is based on the temperature and light intensity 
for Northern Europe in regard to the strains cultivated. 
 
Table 26 LCC outcome for production of Chloridella/Raphidonema in Northern Europe (Optimistic performance) 
 Values for Chloridella/Raphidonema 
Scenario 100 ha 
Cost price EPA (€/kg) 4,017 
Total costs of the supply chain (€/year) 85,825,759 
Total CAPEX (€/year)  45,351,967 
Total OPEX (€/year) 40,473,792 
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Figure 41 Cost components of PUFA production from Chloridella/Raphidonema in Northern Europe (Optimistic 
performance) 
3.5.3 The results of biomass cultivation as cost price 
To assess the performance per scenario the results of the cost price per kilogram dry weight biomass are 
calculated. The cultivation/production of algae is the most significant cost element, for CAPEX and OPEX. 
The dry weight biomass is not the Functional Unit within this research. The assessment is mainly related 
to the performance of the strains, performance scenarios and region for the cultivation/production.  
3.5.3.1 Assessment of biomass cost price in Southern Europe 
In table 27 the total costs (CAPEX and OPEX) combined with the produced dried algae biomass results in 
a potential cost price for algae biomass in Southern Europe. The results are based on the settings 
mentioned above for a potential mature supply chain for 2025.  
 
Table 27 Biomass cost price for Prorocentrum cassubicum, Thalassiosira weissflogii and the ACR option (Chloridella 
simplex and Raphidonema nivale Lagerheim) for Southern Europe (Conservative and Optimistic performance) 
Value for: Prorocentrum cassubicum Thalassiosira weissflogii Chloridella/ Raphidonema 
Scenario 10 ha 100 ha 10 ha 100 ha 10 ha 100 ha 
CAPEX (EUR/year) 2,770,720 25,558,004 2,770,720 25,558,004 2,988,080 27,940,604 
OPEX (EUR/year) 4,500,615 49,458,927 3,726,830 37,757,253 4,283,106 46,067,119 
Total Costs year 
(Production - drying) 7,271,334 75,016,931 6,497,550 63,315,257 7,271,186 74,007,722 
Algae dried biomass 
(DW kg/year) 356,307 4,086,052 356,307 4,086,052 228,131 2,671,290 
Algae biomass cost 
price (€/kg) 20.41 18.36 18.24 15.50 31.87 27.70 
 
The algae cultivation costs make up a significant part of the overall supply chain. The assessment of the 
cost price for cultivation of algae could provide valuable insight in economic effects of improvement options. 
This specifically for cultivation of algae biomass. 
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3.5.3.2 Assessment of biomass cost price in Central Europe 
In table 28 the total costs (CAPEX and OPEX) combined with the produced dried algae biomass results in 
a potential cost price for algae biomass in Central Europe. The results are based on the parameter 
mentioned above for a potential mature supply chain for 2025. 
 
Table 28 Biomass cost price for Prorocentrum cassubicum, Thalassiosira weissflogii and the ACR option (Chloridella 
simplex and Raphidonema nivale Lagerheim) for Central Europe (Conservative and Optimistic performance) 
Value for: Prorocentrum cassubicum Thalassiosira weissflogii Chloridella/ Raphidonema 
Scenario 10 ha 100 ha 10 ha 100 ha 10 ha 100 ha 
CAPEX (EUR/year) 3,262,375 30,212,389 3,262,375 30,212,389 3,429,575 31,942,909 
OPEX (EUR/year) 3,478,202 39,683,358 3,277,921 38,010,785 3,242,314 36,996,756 
Total Costs year 
(Production - drying) 6,740,577 69,895,747 6,540,297 68,223,174 6,671,890 68,939,665 
Algae dried biomass 
(DW kg/year) 237,533 2,724,034 237,533 2,724,034 165,399 1,936,735 
Algae biomass cost 
price (€/kg) 28.38 25.66 27.53 25.04 40.34 35.60 
 
The algae cultivation costs make up a significant part of the overall supply chain. The assessment of the 
cost price for cultivation of algae could provide valuable insight in economic effects of improvement options. 
This specifically for cultivation of algae biomass. 
3.5.3.3 Assessment of biomass cost price in Northern Europe 
In table 47 the total costs (CAPEX and OPEX) combined with the produced dried algae biomass results in 
a potential cost price for algae biomass in Northern Europe. The results are based on the parameter 
mentioned above for a potential mature supply chain for 2025. 
 
Table 29 Biomass cost price for the ACR option (Chloridella simplex and Raphidonema nivale Lagerheim) for 
Northern Europe (Optimistic performance) 
Value for: Chloridella/ Raphidonema 
Scenario 100 ha 
CAPEX (EUR/year) 43,201,787 
OPEX (EUR/year) 34,380,892 
Total Costs year 
(Production - drying) 77,582,679 
Algae dried biomass 
(DW kg/year) 1,488,570 
Algae biomass cost 
price (€/kg) 52.12 
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3.6 Life Cycle Costing Analysis 
The goal of this analysis below is to determine the impact of improvement strategies. The strategies that 
could improve the overall cost price. The calculations result in a cost price for EPA/DHA/SDA in € per 
kilogram (Functional Unit). The production (cultivation) costs are the most significant cost aspect in all 
scenarios. Depending on scenario, production costs vary between 62 % and 80 % of the total costs. 
Therefore, three options are analysed to determine sensitivity of the cost prices to changes in the following 
components:  
- Increasing biomass production yield 
- Decreasing CAPEX  
- Decreasing OPEX  
 
The cultivation of algae is the most significant cost element. The biomass yield influences the overall 
results. The analysis below could give an indication on the effect of such an increase. The algae strains 
could potentially achieve higher yields. This analysis also could provide input for strain selection in the 
future. 
 
The CAPEX is based on current price quotations. The costs could be lowered due to the scale of the 
scenarios chosen, Conservative performance (10 ha) and Optimistic performance (100 ha). This economy 
of scale is not fully incorporated into the current price quotations. This justifies the analysis of a decrease 
in CAPEX costs. 
 
The OPEX is also based on current knowledge and price quotations. A large-scale production of algae is 
expected to lead to multiple improvement in the operation of algae cultivation and further downstream 
processing. A number of improvements combined is expected to at least 5 % till 10 %. 
 
The algae strain Prorocentrum cassubicum was chosen as example for the analysis. CAPEX and OPEX 
are based on multiple costs elements. The most significant CAPEX is for land and production equipment 
(UHT-PBR). The most significant OPEX are labour, water and electricity. For both CAPEX and OPEX a 
fixed percentage is used to determine the effect on cost price. The overall CAPEX or OPEX is lowered 
based on this percentage. 
 
Additionally, two specific elements, land and electricity costs, are analysed. The reason is the high share 
in CAPEX cost of cultivation/production and the sustainability option to used renewable energy. In this case 
an additional solar park as energy source for the algae cultivation site. 
3.6.1 Analysis for Southern Europe 
The analysis for Southern Europe (Lisbon) results in the following changes in cost price: 
Table 30 LCC sensitivity analysis for increased biomass production yield of Prorocentrum in Southern Europe 
(Conservative and Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 848  € 704  
Increased production strategies     
Cost price EPA/DHA/SDA (€/kg) at 5% extra € 807 95% € 671 95% 
Cost price EPA/DHA/SDA (€/kg) at 10% extra € 770 91% € 640 91% 
Cost price EPA/DHA/SDA (€/kg) at 15% extra € 737 87% € 612 87% 
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Table 31 LCC sensitivity analysis for decreased CAPEX for Prorocentrum in Southern Europe (Conservative and 
Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 848  € 704  
Decreased production CAPEX strategies     
Cost price EPA/DHA/SDA (€/kg) at 5% less € 834 98% € 694 99% 
Cost price EPA/DHA/SDA (€/kg) at 10% less € 820 97% € 683 97% 
Cost price EPA/DHA/SDA (€/kg) at 15% less € 807 95% € 673 96% 
 
Table 32 LCC sensitivity analysis for decreased OPEX for Prorocentrum in Southern Europe (Conservative and 
Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 848  € 704  
Decreased production OPEX strategies     
Cost price EPA/DHA/SDA (€/kg) at 5% less € 833 98% € 689 98% 
Cost price EPA/DHA/SDA (€/kg) at 10% less € 818 97% € 674 96% 
Cost price EPA/DHA/SDA (€/kg) at 15% less € 804 95% € 660 94% 
 
The analysis for Southern Europe indicates the potential priorities for businesses to improve the overall 
performance of the PUFA supply chain. The increase in yield a strong effect on the overall performance. 
This for the Conservative and Optimistic performance scenarios. For Southern Europe a second focus 
could be lowering the OPEX. As mentioned before labour, water and electricity are the main costs elements 
in algae cultivation. A focus on reducing input or cost of inputs would improve the overall performance of 
the supply chain. The lowering of cost of CAPEX is the third option. The algae cultivation is a logical option, 
since the CAPEX of algae production is the main cost element. The focus on all three options analysed is 
expected. The analysis could provide insight in the decision-making process in aspects were links between 
CAPEX and OPEX exist. For example, a higher investment in installations to save energy input. 
3.6.2 Analysis for Central Europe 
The same analysis was performed for Central Europe (Munich) since yield and overall costs for Munich are 
slightly different. For example, labour and land costs quotations used are higher than for Southern Europe 
(Lisbon). 
 
Table 33 LCC sensitivity analysis for increased biomass production yield of Prorocentrum in Central Europe 
(Conservative and Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 1,196  € 997  
Increased production strategies     
Cost price EPA/DHA/SDA (€/kg) at 5% extra € 1,139 95% € 950 95% 
Cost price EPA/DHA/SDA (€/kg) at 10% extra € 1,087 91% € 907 91% 
Cost price EPA/DHA/SDA (€/kg) at 15% extra € 1,040 87% € 867 87% 
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Table 34 LCC sensitivity analysis for decreased CAPEX for Prorocentrum in Central Europe (Conservative and 
Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 1,196  € 997  
Decreased production CAPEX strategies     
Cost price EPA/DHA/SDA (€/kg) at 5% less € 1,172 98% € 979 98% 
Cost price EPA/DHA/SDA (€/kg) at 10% less € 1,147 96% € 960 96% 
Cost price EPA/DHA/SDA (€/kg) at 15% less € 1,123 94% € 941 94% 
 
Table 35 LCC sensitivity analysis for decreased OPEX for Prorocentrum in Central Europe (Conservative and 
Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 1,196  € 997  
Decreased production OPEX strategies     
Cost price EPA/DHA/SDA (€/kg) at 5% less € 1,180 99% € 980 98% 
Cost price EPA/DHA/SDA (€/kg) at 10% less € 1,165 97% € 963 97% 
Cost price EPA/DHA/SDA (€/kg) at 15% less € 1,149 96% € 945 95% 
 
Similar to Southern Europe an increased biomass production yield is also for Central Europe the most 
viable option for improvement of overall performance. The changes in OPEX are less significant for 
improvement for Central Europe (Munich) than for Southern Europe (Lisbon). CAPEX on the other hand 
are more significant for Central than for Southern Europe. An improved scenario for Central Europe could 
be advised that it should first focus on increased biomass production yield, followed by cost reductions of 
the CAPEX and finally OPEX. As mentioned for Southern Europe the focus on all three options analysed 
is expected. The analysis could provide insight in the decision-making process in aspects were links 
between Yield, CAPEX and OPEX exist. 
3.6.3 Land and electricity costs 
Land costs are the most significant CAPEX while electricity costs are the most significant OPEX. Land 
costs constitute between 70 % and 79 % of CAPEX depending on scenario or location. Therefore, the 
effects of decreased land costs are calculated. The land costs for the alternative locations are based on 
price listings of real estate agents.  
 
Table 36 Decreased land cost effects for Southern Europe (Conservative and Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 848  € 704  
Decreased land costs (€20/m2)     
Cost price EPA/DHA/SDA (€/kg)  € 670 79% € 558 79% 
 
Table 37 Decreased land cost effects for Central Europe (Conservative and Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 1,229  € 1,022  
Decreased land costs (€25/m2)     
Cost price EPA/DHA/SDA (€/kg)  € 864 72% € 725 73% 
 
As mentioned in the general observations current scenarios are all located in the vicinity of big cities/capitals 
of each country. As such, the land prices of more urban areas are used. A shift towards a more rural area 
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would have a significant effect on cost prices. Due to the higher land price for Munich region lowering them 
has a more significant impact on the Central Europe scenario. 
A number of alternative options addressed as recommendations in Keller et al., 2017a. The option 
addressed have the potential to reduce costs of land needed for algae cultivation, including the 
environmental impact. This would directly and positively influence the economic viability of the whole PUFA 
supply chain.   
 
The use of renewable energy is an option that potentially could improve both economic and environmental 
performance. The substantial need for electricity in algae cultivation and further processing and the reported 
drop in investment costs for solar parks was a reason to research this option. The lower electricity costs 
are based on a market report with solar power plant installations bids for Europe (SolarPowerEurope, 
2016), which mentioned electricity prices for Portugal and for Germany of € 0.05/kWh and € 0.08/kWh 
respectively. The effect of the reduced electricity price was calculated on the electricity use of the supply 
chain except the extraction and oil processing. 
 
Table 38 Decreased electricity cost effects for Southern Europe (Conservative and Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 870  € 722  
Lower electricity costs (€ 0.05/kWh)     
Cost price EPA/DHA/SDA (€/kg)  € 770 91% € 650 92% 
 
Table 39 Electricity cost effects for Central Europe (Conservative and Optimistic performance scenario) 
 Values for Prorocentrum cassubicum 
Scenario 10 ha  100 ha  
Cost price EPA/DHA/SDA (€/kg) € 1,229  € 1,022  
Lower electricity costs (€ 0.08/kWh)     
Cost price EPA/DHA/SDA (€/kg)  € 1,107 93% € 932 93% 
 
A local renewable energy power plant, especially solar based, could thus provide cheaper electricity and 
could also reduce the CO2-emissions related to electricity use. Similar to alternative land options, the solar 
park option could potentially improve the economic viability and the environmental impact. 
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3.7 Recommendations  
The LCC offers insights and options for improvements for a mature supply chain for 2025. Further 
recommendations on the overall sustainability can be found in Keller et al, 2017b. The following 
recommendations can be made and are related to the micro-economic assessment. 
3.7.1 General aspects 
 
Costs of land 
A general recommendation is that the scenarios were based on the geographical locations Lisbon, Munich 
and Oslo, relatively expensive regions in terms of land costs. The land costs were taken into account for 
the calculations and thus constitute a significant part of CAPEX. One of the recommendations is to 
investigate alternative locations with similar geographical settings, but with a lower land costs. As 
mentioned in Keller et al. 2017a, options as brownfield sites and restored opencast mining sites could 
provide economic and sustainable alternatives to existing industrial area used in the economic modelling. 
A well-chosen location could significantly improve the economic viability of a mature PUFA supply chain.  
  
Renewable energy 
As part of the integrated sustainability analysis the option of solar power as source of electricity was 
investigated (Keller et al., 2017a). Price reductions in recent years for realisation of solar parks lead to a 
positive outcome of this option. This option could improve the economic outcome, but also reduce CO2-
emissions per FU.  
The productivity of algae and the production of solar based electricity shows similarities in production 
profile. An additional recommendation is to research potential benefits of these matching production 
profiles. 
3.7.2 Supply chain specific aspects 
 
Yields and algae strain selection 
The most important recommendation is to focus efforts for improvement of or increasing biomass 
production yields. For both Southern and Central Europe an increase in production led to nearly 1-to-1 
improvement of the overall cost price. Another element is EPA/DHA/SDA yield during processing steps. 
Efficiency in cell disruption and losses during purification for example have significant impacts on overall 
EPA/DHA/SDA yield. An ideal algae strain combines a high biomass yield in biomass and EPA/DHA/SDA 
and good processing properties. The recommendation is to further research suitable algae strains for PUFA 
production. 
 
CAPEX and OPEX reduction 
Two other aspects influencing overall cost price are CAPEX and OPEX. Both showed an improvement in 
cost reductions. There are similarities in results between Southern (Lisbon) and Central Europe (Munich) 
for changes in CAPEX and OPEX. For Southern Europe the improvement of OPEX has a slightly bigger 
effect than for Central Europe. For Central Europe the improvement of CAPEX has a slightly bigger effect 
than for Southern Europe. All in all, efforts should be made on all aspects of the supply chain for PUFAs 
from phototrophic algae. Both scenarios, Conservative (10 ha) and Optimistic (100 ha) performance, are 
significantly bigger than any algae production facilities build based on Photo BioReactors (PBR). A certain 
economy of scale could be expected. As well as technological advances that also reduce CAPEX and/or 
OPEX. 
  
  
 
 
 
 
74 
 
By-products and waste streams 
In the economic modelling the by-product of supercritical CO2-extraction is expected to be used as input 
for anaerobic digestion. This is a low value option. The by-product(s) of oil processing are discarded. It is 
recommended that all by-products and waste stream should be assessed to achieve their full economic 
potential. This in order to achieve a mature PUFA supply chain. 
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4 SWOT for the mature PUFAChain 
By: Jorieke Potters 
 
Figure 42 shows a SWOT analysis for the mature PUFAChain. Explanations of the different strengths, 
weaknesses, opportunities and threats can be found in the text below.   
 
 
Figure 42 SWOT analysis for PUFAChain 
4.1 Strengths 
The production of omega-3 from phototrophic algae has several strong advantages compared to other 
sources of omega-3. These are relevant depending on the type of product and the mode of production that 
are being developed. Each one of them will be explained briefly also indicating the circumstances under 
which these strengths are most relevant. 
Composition DHA/EPA 
The selection of specific algae strains for DHA and EPA holds the promise of producing pure DHA and 
EPA. This is an important feature since it enables precise dosing for specific purposes. It is possible to 
obtain pure EPA and DHA from fish oil, but this requires an expensive separation process. Heterotrophic 
microorganisms mainly produce DHA. The question whether it is possible to obtain pure EPA or DHA 
economically on an industrial scale out of phototrophic algae is still to be answered. It depends on the strain 
used, the production, the extraction and purification process. 
Production process 
The production process of omega-3 from algae has the following features that positively resonate with 
societal demands and concerns.  
STRENGHTS
Composition DHA/EPA
Production process
Production in northern countries
Pure product
High value product
Mixotrophic system
By-products of algae production
WEAKNESSES
Energy consumption in the production of algae 
Immature production process
Profitability of the production process
OPPORTUNITIES
Declining fish stocks
Growing market 
Positive image of algae 
THREATS
New competitors 
More strict regulations 
GMO more widely allowed
Dropping market prices
New insights on health effects DHA/EPA
Sustainability questioned
PUFAChain
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Pressure on wild fish stocks: As compared to fish and krill based omega-3, algal omega-3 has the 
advantage of not contributing to the pressure on oceanic resources.  When omega-3 is made out of cuttings, 
by-catch and left overs of consumption fish, the advantage is less demarcated.  
Environmentally friendly: Potentially the cultivation of phototrophic algae could be environmental friendly, 
since it uses (instead of produces) CO2. However, the production chain causes substantial CO2 emissions 
elsewhere and should therefore should be substantially optimized for other aspects will this aspect be of 
high importance (Keller et al, 2017a). An in-depth analysis whether the whole life cycle saves CO2 or 
causes additional CO2 emissions is needed. 
Reduced pressure on arable land: For the production of phototrophic algae no arable land is needed. Even 
though land area is needed for the production units, this can be on industrial or marginal lands. This is an 
advantage compared to the production of heterotrophic microorganisms, where arable land is needed for 
the production of sugar. However, input of limited resources is currently still a requirement (Keller et al, 
2017). 
Origin and characteristics of the product: Omega-3 from phototrophic algae stems from a plant source and 
it can be labelled a vegan/vegetarian, biobased, halal and kosher product. Furthermore, it is a non-GM 
source. These are arguments that gain power in recent years since consumers have become more 
concerned about the origin of their food.  
Production in northern countries 
It is a specific aim of the PUFAChain to select algae strains that can be produced in northern European 
countries. This strength is relative since heterotrophic microorganisms depend less on climatic 
circumstances, thus can be produced anywhere. Whether it is possible to create a suitable production line 
for phototrophic algae under cold circumstances is to be seen. 
Pure product 
Fish and fish oil as a source of omega-3 have an important disadvantage of contamination with heavy 
metals and dioxin. This presents a health risk or requires an expensive purification processes. The 
production of omega-3 from algae source enables a pure product. Besides the absence of contaminants, 
algal oil from the PUFAChain process also does not contain organic solvents. 
High value product 
The PUFAChain aims at producing pure EPA and DHA. Especially pure EPA is very scarce and in high 
demand at the higher end of the market. This strengthens the chances for creating a profitable production 
chain. 
Combination with heterotrophic microorganism production (mixotrophic system) 
A combination of phototrophic algae and heterotrophic microorganism production, in two separate 
production installations, can result in several advantages. The heterotrophic system is specialised in DHA 
whereas in the phototrophic system EPA could be produced. The combination of both types of omega-3 
presents interesting opportunities for blending specific recipes for the pharma market. The CO2 that is 
produced in the heterotrophic system can be used as input in the phototrophic system. In winter production 
the heat from the heterotrophic system can be used for warming the phototrophic system. In this way the 
efficiency and profitability of the PUFAChain can be increased.   
By-products of algae production 
The protein-rich algae cake that results after extracting the PUFA provides opportunity to raise profitability 
by selling it for feed.   
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4.2 Weaknesses 
Opposite the strengths are some weaknesses. These consist of risks on one hand and insecurities in the 
development of the PUFAChain on the other. Each one of them will be explained briefly also indicating the 
circumstances under which these weaknesses are most relevant: 
Energy consumption in the production of algae 
The production of phototrophic algae requires a constant mixing of the liquid in order to optimise exposure 
to light and to CO2. This requires a constant pumping of the liquid in the tubes and causes high energy 
consumption. This could be reduced by adding solar panels to the plant (4.7.3), however this is more a 
means to compensate for energy use than to reduce the energy footprint of the phototrophic production 
process.  
Immature production process 
Omega-3 production from fish oil and heterotrophic microorganisms is already in business at commercial 
levels. The production process for PUFA from phototrophic algae is still in development and leaves a lot of 
questions to be answered and technical details to be investigated. The challenge is to produce a DHA and 
EPA in a profitable matter. The main challenges lie in the selection of the algae strains, optimise the algae 
production process, and finally the extraction of the oil and DHA/EPA, purification and storage. These 
challenges are further described in the technical assessment.  Below for each production step the main 
questions and weaknesses that come with it are described:   
Selection of algae: Despite the large collection of phototrophic algae, little is known about the characteristics 
and potential of the available algae strains. Since also the characteristics depend very much on the 
production circumstances, a lot of experimentation time is needed to select the most promising strains for 
different purposes and determine the optimum production circumstances. In the PUFAChain project 
important steps have been made in learning about production and processing. 
Production: Once the strains are selected it is necessary to optimise the production process. This is not 
just a question of maximising dry matter production, since the content of EPA/DHA/SDA depend on the 
growing circumstances. For each alga strain the optimum growing conditions should be determined. 
Extraction: the different algae strains have different types of cell membranes which differ in the ease of 
rupture. Furthermore, algae strains differ in the way they store their oil; in phospholipids, triglycerides or 
ethyl esters, each require a different extraction process with each its own challenges. The question is how 
to get the most omega-3 out of the different algae strains. 
Purification: Once the oil is extracted from the algae, the effort needed to purify the algal oil depends for 
example on the lipid concentration and lipid class in the algae (e.g. Robles Medina et al, 1998). A lot of 
experimentation and investigation is needed to optimise the purification process. 
Shelf life: Stability and storage of the product (shelf life), is another step where experimentation and 
experience are needed. 
Profitability of the production process 
In the present state of development, the profitability of the PUFAChain is a weakness. The profitability is 
weak at four levels.  
Productivity of phototrophic production: Since phototrophic production of algae is still under development, 
the productivity is not optimal yet. Improvements can be expected in increased lipid yield and productivity 
(2-8 fold, by exploiting the physiological potential, improving strains by selection, breeding and genetic 
modification; Chauton et al, 2015).   
Difficulty to patent: Many systems and methods related to the production of omega-3 from phototrophic 
algae have been patented already.   
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Business plan uncertain: At this stage it is possible to formulate a lucrative business case for the production 
of omega-3 from phototrophic production process at competitive cost prices compared to other omega-3 
sources, but this is still an optimized scenario for 2025 (Chapter 4). 
Extensive authorization procedure: The use of omega-3 (rich oils) from fish products and certain unicellular 
marine heterotrophic organisms is already authorised for different market segments, e.g. from 
Schizochytrium sp. None of such authorization seems to exist for pure omega-3 from phototrophic algae, 
only for complete algae like Nannochloropsis gaditana. This means before being able to market it, an 
application for authorisation of use in food, feed or pharma needs to be made presenting the scientific 
information and safety assessment report. A shorter route could be to apply for a ‘notification’ arguing that 
substantial equivalence exists to the already authorized omega-3 from unicellular marine heterotrophic 
organisms. 
4.3 Opportunities 
The present situation holds a number of opportunities for the production and marketing of omega-3 from 
phototrophic algae. Various opportunities result from the specific characteristics of the production process 
or from developments in the market through pricing or consumers’ interest.  
Declining fish stocks 
The fact that the main source of omega-3 is declining, creates momentum for alternatives, thus giving 
alternatives such as omega-3 from phototrophic algae room for entering the market.  
Growing market  
In general, the market for EPA and DHA steadily increases due to a growing interest in health and food. 
There is quit a strong lobby to create more awareness on the positive effects of DHA/EPA for human health. 
Within this general growing market for omega-3, the potential market for vegan/vegetarian DHA/EPA is 
increasing since veganism is slowly growing and environmental awareness follows the same trend. The 
existing pharma market provides interesting sales opportunities for pure DHA and EPA.  
Positive image of algae  
Regardless of the specific production process or end products, the green colour in combination with clean 
production on the basis of sunlight using CO2, provides good opportunities for marketing algae as a 
sustainable alternative.  
4.4 Threats 
The present situation holds a number of threats that could have a negative effect on the development of 
the PUFAChain production process. 
New competitors  
Since the market for PUFA is growing new producers of omega-3 from algae or yeast could enter this 
market as competitors. This could be either on cost price or on the quality of the product. 
More strict regulations  
When the rules for the use of algae products for pharma, food and feed become stricter this will reduce the 
market share for PUFA from algae. 
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GMO more widely allowed 
In the US GM yeasts are being developed as vegan source for PUFA. This presents an important competitor 
in the US market. In case the use of GMO will be allowed in Europe this poses a serious threat that could 
compete on cost price. It can however be expected that the vegan/vegetarian consumer will not accept GM 
PUFA production.  
Dropping market prices 
The market price for PUFA may drop due to higher availability of PUFAs from other sources, increased 
production or decreased demand for example due to reasons mentioned below. 
New insights on health effects DHA/EPA 
Ongoing research on the health effects could result in new insights on the health effects of DHA and EPA. 
This could be positive, but it is also thinkable that research reduces the positive expectations of PUFA in 
food and pharma. These insights could for example show that the health effects of pure DHA and EPA are 
less favourable than those of PUFA in fish or vegetables. It could turn out that EPA and DHA have negative 
side effects on health or that DHA and EPA do not have such a strong effect on health as is currently 
thought. As a result, the demand will decrease.  
Sustainability questioned 
Another cause of decreasing demand could be the public questioning of sustainability of PUFA from algae.  
Socio-economic assessment of Algae-based PUFA production © PUFAChain, 2017 
   
5 Indicators for LCC and socio-economic analyses 
By: Marcel van der Voort & Jorieke Potters 
 
P= Prorocentrum, T= Thalassiosira, C/R = Chloridella/Raphidonema and S= South, W = West, N = North 
Het = PUFAs from heterotrophic microorganisms, F = PUFAs from fish cuttings, B= PUFAs from by-catch 
 
 
1) Phototrophic can be produced on unproductive land, heterotrophic needs sugar. For differences between Nordic and southern locations see socio-economic analysis. 
2) Production site may be observed as negative to landscape, this effect is less in less densely populated areas. Production could have a positive effect on the living 
conditions through economic development in remote areas in Portugal 
3) Heterotrophic contributes as much as phototrophic to health, fish a bit less because of possible impurities and contamination 
4) Fish oil production is linked to unsustainable fisheries 
5) Heterotrophic algae are already authorised for different markets, fish oil is accepted though some discussion about its use in baby formula    
6) Fish oil production is linked to unsustainable fisheries 
 
  
 
Indicator Unit P_S T_S C/R_S P_W T_W C/R_W C/R_N P_S T_S C/R_S P_W T_W C/R_W C/R_N Het F B
                  
Production costs €/kg PUFAs 848 1,359 1,156 1,196 2,058 2,344 N/D 704 468 932 997 753 1,915 3,903 900 900 850
Fixed capital investment Million € 59 59 61 68 68 70 N/D 545 545 569 628 628 645 867 N/D N/D N/D
                
Labour conditions Health
- + + + + + + + + + + + + + + + + +
Labour conditions 
(Safety)
- + + + + + + + + + + + + + + + - -
Employment opportunity - ++ ++ ++ + + + + ++ ++ ++ + + + + + 0 0
Access to material 
resources (1)
- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0
Living Conditions (2) - + + + 0 0 0 0 + + + 0 0 0 0 0 0 0
General society
Consumers' health and 
safety (3)
- ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ + +
Public commitment to 
sustainability issues (4)
- + + + + + + + + + + + + + + + - - - -
Legal regulatory barriers 
(5)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - ++ + +
Public perception (6) - ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ + - -
Standard conditions
PUFAChain scenarios PUFAChain scenarios Alternatives to PUFAChain
Local community
Least expected performance Optimistic performance
Legend:
worst 20% of 
range
20%-40% of 
range
average 
+/- 10%
60%-80% of 
range
best 20% of 
range
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